Data / Research funding / Arthritis
Arthritis: 1,149 NIH awards ($1.3B) to 276 organizations
1,149 NIH awards ($1.3B) in the NIH spending category Arthritis, to 276 organizations, read 2026-11-04. NIH fiscal years 2021 to 2025.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- Topic
- NIH spending category
Awards
The 500 largest of 1,149 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| Accelerating Medicines Partnership-Autoimmune and Immunologic Disease Tissue Research Core | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $19,601,747 | March 23, 2022 | December 31, 2026 | GUTHRIDGE, JOEL MARVIN | reporter.nih.gov |
| EPPIC-Net Pain Research - Application for Clinical Trial and Related Activities (OT2) | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $19,316,294 | January 1, 2021 | July 31, 2026 | FAVA, MAURIZIO | reporter.nih.gov |
| Center for Addiction and Disease Risk Exacerbation | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $12,487,946 | August 1, 2019 | July 31, 2029 | MONTI, PETER M. | reporter.nih.gov |
| Mapping the joint-nerve interactome of the knee | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $11,877,917 | September 23, 2022 | August 31, 2027 | MALFAIT, ANNE-MARIE | reporter.nih.gov |
| Center for Musculoskeletal Disease Research (CMDR) | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $11,683,826 | February 16, 2018 | January 31, 2028 | O'BRIEN, CHARLES A | reporter.nih.gov |
| Innervation of the knee and TMJ | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $10,814,779 | September 23, 2022 | August 31, 2027 | ALLEN, KYLE D | reporter.nih.gov |
| Increasing the Efficiency of RE-JOIN Through Data Sharing and Integration | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $10,788,004 | September 23, 2022 | July 31, 2027 | LEE, BRENDAN | reporter.nih.gov |
| A sequenced-strategy for improving outcomes in patients with knee osteoarthritis pain | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2023 | $10,487,739 | September 25, 2019 | August 31, 2025 | CAMPBELL, CLAUDIA MICHELLE | reporter.nih.gov |
| CLINICAL STUDIES MANAGEMENT AND SUPPORT (CSMS) - SOLE SOURCE BRIDGE CONTRACT | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $8,078,483 | September 30, 2021 | January 24, 2025 | YOU, HUIQING | reporter.nih.gov |
| The Osteoarthritis Prevention Study (TOPS) | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 to 2025 | $7,779,027 | August 10, 2023 | July 31, 2028 | MESSIER, STEPHEN P | reporter.nih.gov |
| Daily & Localized NSAID Sonophoresis for Symptomatic Treatment of Knee Osteoarthritis | NIH | National Institute on Aging | 2021 to 2025 | $7,422,310 | September 20, 2024 | May 31, 2027 | LEWIS, GEORGE KENNETH | reporter.nih.gov |
| Clinical-Translational Studies in Skin, Lung, and Vascular Complications in Systemic Sclerosis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $6,366,452 | September 20, 2022 | August 31, 2027 | LAFYATIS, ROBERT A. | reporter.nih.gov |
| Deciphering the Genomics of Gene Network Regulation of T Cell and Fibroblast States in Autoimmune Inflammation | NIH | National Human Genome Research Institute | 2021 to 2025 | $6,348,798 | August 20, 2021 | May 31, 2027 | LESLIE, CHRISTINA S | reporter.nih.gov |
| Phase II trial of GM-CSF/sargramostim in Alzheimer's Disease | NIH | National Institute on Aging | 2021 to 2023 | $6,265,868 | February 1, 2021 | November 30, 2026 | POTTER, HUNTINGTON | reporter.nih.gov |
| Treat-to-Target Serum Urate versus Treat-to-Avoid Symptoms in Gout: A Randomized Controlled Trial (TRUST) | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 to 2025 | $5,795,791 | September 1, 2023 | July 31, 2028 | CHOI, HYON K | reporter.nih.gov |
| Remote Tai Chi for Knee Osteoarthritis: an Embedded Pragmatic Trial | NIH | National Center for Complementary & Integrative Health | 2024 to 2025 | $5,587,756 | May 19, 2023 | August 31, 2028 | WANG, CHENCHEN | reporter.nih.gov |
| Structure-Function Analysis of Mxra8 Interaction with Alphaviruses | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $5,414,348 | June 1, 2019 | July 31, 2029 | DIAMOND, MICHAEL S | reporter.nih.gov |
| Methotrexate treatment of Arthritis caused by Chikungunya virus (MARCH): A randomized controlled trial of methotrexate versus placebo in the treatment of chronic arthritis after chikungunya infection | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2024 | $5,036,160 | September 1, 2022 | August 31, 2027 | CHANG, AILEEN | reporter.nih.gov |
| Leveraging inter-individual differences in walking pain and impairment to elucidate whole-person mechanisms of knee osteoarthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2025 | $4,899,748 | September 19, 2025 | August 31, 2029 | ALTER, BENEDICT J | reporter.nih.gov |
| Activation of Macrophages in Human Autoimmune Diseases | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $4,710,162 | March 1, 2000 | July 31, 2029 | IVASHKIV, LIONEL B | reporter.nih.gov |
| Integrative Network Biology Approaches to Identify, Characterize and Validate Molecular Subtypes in Alzheimer's Disease | NIH | National Institute on Aging | 2021 to 2022 | $4,709,163 | May 15, 2014 | August 31, 2023 | ZHANG, BIN | reporter.nih.gov |
| Chemical probes to decipher PAD biology | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $4,690,000 | June 1, 2016 | May 31, 2026 | THOMPSON, PAUL R | reporter.nih.gov |
| PANDA-MSD: Predictive Analytics via Networked Distributed Algorithms for Multi-System Diseases | NIH | National Center for Advancing Translational Sciences | 2022 to 2025 | $4,670,835 | August 5, 2022 | May 31, 2027 | CHEN, YONG | reporter.nih.gov |
| Network modeling as a unified framework to understand inter-individual differences in chronic musculoskeletal pain | NIH | National Center for Complementary & Integrative Health | 2025 | $4,649,740 | August 15, 2025 | July 31, 2029 | SIKDAR, SIDDHARTHA | reporter.nih.gov |
| Monitoring of disease-induced skin VOC patterns from handheld and wearable chemical sensors | NIH | National Center for Advancing Translational Sciences | 2022 to 2025 | $4,608,903 | June 22, 2022 | May 31, 2027 | DAVIS, CRISTINA ELIZABETH | reporter.nih.gov |
| Development of the INI-4001 and INI-2002 adjuvants within the context of a vaccine to prevent Lyme disease. | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $4,583,801 | September 30, 2018 | September 29, 2024 | EVANS, JAY | reporter.nih.gov |
| Clinical Optimization of Ultrasonic Drug Delivery Technologies for US Veteran Populations that Experience Health Disparities with Arthritis and Chronic Pain | NIH | National Institute on Minority Health and Health Disparities | 2023 to 2025 | $4,518,543 | September 14, 2020 | February 28, 2026 | LEWIS, GEORGE KENNETH | reporter.nih.gov |
| AIM-for-RA | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $4,499,382 | March 22, 2022 | December 31, 2026 | ANOLIK, JENNIFER HOWITT | reporter.nih.gov |
| Small molecule targeting an epigenetic regulator for the treatment of osteoarthritis | NIH | National Institute on Aging | 2021 to 2024 | $4,178,124 | September 30, 2021 | May 2, 2025 | ADORNO, MADDALENA | reporter.nih.gov |
| Elucidating Factors Contributing to Disparities in Neurobiological Vulnerabilities and Alzheimers Disease and Related Dementias Risk | NIH | National Institute on Aging | 2021 to 2023 | $4,137,397 | April 1, 2009 | February 28, 2025 | FILLINGIM, ROGER B | reporter.nih.gov |
| Molecular basis of bioelectronic medicine | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $3,937,630 | May 1, 2016 | April 30, 2027 | TRACEY, KEVIN J | reporter.nih.gov |
| ELLIPSS: ELucidating the Landscape of Immunoendotypes in Psoriatic Skin and Synovium | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $3,900,002 | March 21, 2022 | December 31, 2026 | RITCHLIN, CHRISTOPHER TREVOR | reporter.nih.gov |
| Osteoarthritis Progression And Sensory Pathway Alterations | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $3,899,677 | May 1, 2013 | July 31, 2029 | MALFAIT, ANNE-MARIE | reporter.nih.gov |
| RESOURCE BASED CENTER FOR MUSCULOSKELETAL BIOLOGY AND MEDICINE | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $3,860,791 | April 15, 2019 | June 30, 2029 | SILVA, MATTHEW J | reporter.nih.gov |
| Adalimumab in Juvenile Idiopathic Arthritis-associated Uveitis Stopping Trial | NIH | National Eye Institute | 2021 to 2023 | $3,733,343 | May 1, 2019 | April 30, 2026 | ACHARYA, NISHA | reporter.nih.gov |
| CNS Pain Mechanisms in Early Rheumatoid Arthritis: Implications for the Acute to Chronic Pain Transition | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $3,704,355 | July 1, 2013 | April 30, 2027 | LEE, YVONNE CLAIRE | reporter.nih.gov |
| Single cell and spatial genomic analyses of specimens from patients with autoimmune diseases (Technology Core) | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $3,700,281 | March 22, 2022 | December 31, 2026 | BRENNER, MICHAEL B. | reporter.nih.gov |
| Rheumatoid Arthritis-Related Autoantibodies, Articular Inflammation, and RA-Associated Interstitial Lung Disease | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $3,692,582 | September 27, 2021 | June 30, 2027 | SPARKS, JEFFREY ANDREW | reporter.nih.gov |
| ADalimumab Vs. conventional ImmunoSupprEssion for uveitis(ADVISE) Trial | NIH | National Eye Institute | 2021 to 2022 | $3,613,158 | September 30, 2018 | August 31, 2025 | HOLBROOK, JANET T. | reporter.nih.gov |
| Peripheral blood mononuclear cell epigenetic associations in and biomarkers for knee osteoarthritis development and progression | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $3,596,032 | June 16, 2020 | August 31, 2028 | JEFFRIES, MATLOCK | reporter.nih.gov |
| Cannabidiol for postoperative Opioid Reduction in primary total Knee arthroplasty – a randomized, 2x2 factorial, double-blind, placebo-controlled clinical trial (The CORK trial) | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 to 2025 | $3,579,362 | September 18, 2023 | August 31, 2028 | BRUMMETT, CHAD M | reporter.nih.gov |
| Structural, Biochemical and Functional Connectivity in Osteoarthritis using Quantitative Magnetic Resonance Imaging and Skeletal Biomechanics | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $3,536,892 | July 14, 2016 | June 30, 2027 | MAJUMDAR, SHARMILA | reporter.nih.gov |
| Insights Into Immune-Related Diseases Born from Population Genomics | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,513,383 | July 6, 2010 | July 31, 2030 | NORMAN, PAUL JOHN | reporter.nih.gov |
| Biomechanical and Biological Predictors of Cartilage Health Following Meniscus Injury | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $3,493,420 | April 5, 2021 | March 31, 2026 | MCNULTY, AMY L | reporter.nih.gov |
| Studies on gut microbiome-joint connections in arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $3,412,637 | April 1, 2021 | February 28, 2027 | ZUSCIK, MICHAEL J | reporter.nih.gov |
| The Impact of the Bone Marrow Niche's Immune Privilege on Psoriatic Arthritis | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $3,406,145 | August 8, 2025 | July 31, 2029 | FUJISAKI, JOJI | reporter.nih.gov |
| BEAR-MOON: A Two Arm Noninferiority Blinded Randomized Clinical Trial Comparing ACL Repair with BEAR Device vs. Standard of Care Autograft Patellar Tendon ACL Reconstruction | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2024 | $3,403,884 | August 1, 2018 | July 31, 2025 | SPINDLER, KURT PAUL | reporter.nih.gov |
| Innovative modeling of the biopsychosocial model in animals: Validation of outcomes for assessing emotional and cognitive domains affected by naturally-occurring chronic pain in dogs | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 | $3,320,159 | September 18, 2024 | August 31, 2027 | GRUEN, MARGARET ELIZABETH | reporter.nih.gov |
| Microbial Determinants of Excessive Inflammation and Severe Lyme Disease | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $3,315,179 | September 19, 2025 | August 31, 2029 | STRLE, KLEMEN | reporter.nih.gov |
| Impact of Registry Use on Quality and Outcomes in Rheumatology (QORA) | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $3,312,228 | July 16, 2021 | May 31, 2027 | SCHMAJUK, GABRIELA | reporter.nih.gov |
| Wnt7a-Mediated Competence to Resist Osteoarthritis Progression | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $3,282,434 | February 15, 2021 | January 31, 2027 | ZENG, LI | reporter.nih.gov |
| Unmodified and Post Translationally Modified CD4+ and CD8+ T cell Epitopes in Rheumatoid Arthritis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $3,237,408 | September 30, 2019 | September 29, 2023 | BENTON, RYAN | reporter.nih.gov |
| Gut Microbiota Modulation of Chikungunya Virus Infection and Pathogenesis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,216,725 | April 1, 2021 | March 31, 2027 | DIAMOND, MICHAEL S | reporter.nih.gov |
| Psychometric Reliability and Validity for Behavioral Metrics of Osteoarthritic Pain in Horses | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 | $3,196,061 | September 19, 2024 | August 31, 2027 | ALLEN, KYLE D | reporter.nih.gov |
| Imaging post-traumatic osteoarthritis 10-years after ACL reconstruction: a multicenter cohort study with quantitative MRI | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2023 | $3,194,922 | July 16, 2019 | June 30, 2025 | LI, XIAOJUAN | reporter.nih.gov |
| VISTA is a negative checkpoint regulator of innate immunity | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $3,194,465 | May 6, 2020 | April 30, 2025 | SKOPELJA-GARDNER, SLADJANA | reporter.nih.gov |
| Is the gut important in multiple joint osteoarthritis? A multimodal investigation in humans and pet dogs | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $3,176,745 | August 5, 2022 | June 30, 2027 | NELSON, AMANDA E | reporter.nih.gov |
| Multiparametric Mapping of Knee Joint with Magnetic Resonance Fingerprinting | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $3,138,468 | February 1, 2021 | August 31, 2027 | REGATTE, RAVINDER | reporter.nih.gov |
| Identifying determinants of rapid structural and/or clinical progression in knee osteoarthritis by quantitative assessment of structural features on radiographs | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $3,098,703 | August 12, 2022 | June 30, 2027 | KWOH, C KENT | reporter.nih.gov |
| Investigating Mucosal Breaks in the Initiation and Progression of Rheumatoid Arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $3,091,101 | June 23, 2021 | April 30, 2026 | ROBINSON, WILLIAM H | reporter.nih.gov |
| Designing Novel MR Imaging Tools to Quantify Lower-Limb Exercise Adaptations in Knee Osteoarthritis | NIH | National Institute of Biomedical Imaging and Bioengineering | 2021 to 2025 | $2,997,092 | September 20, 2003 | April 30, 2028 | GOLD, GARRY E | reporter.nih.gov |
| Genetically-engineered stem cells for self-regulating arthritis therapy | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $2,983,611 | April 1, 2022 | March 31, 2027 | GUILAK, FARSHID | reporter.nih.gov |
| Proteomic analysis of hydroxychloroquine prevention trials in T1D, RA and SLE | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $2,978,715 | August 18, 2023 | July 31, 2028 | BUCKNER, JANE HOYT | reporter.nih.gov |
| Role of Systemic Inflammation in Cognitive Decline: Rheumatoid Arthritis as a Prototype | NIH | National Institute on Aging | 2021 to 2024 | $2,977,796 | September 30, 2020 | May 31, 2026 | MYASOEDOVA, ELENA | reporter.nih.gov |
| A Novel IL-35 Expressing Probiotic Platform for Inducing Allergen Specific Tolerance | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $2,952,468 | May 1, 2020 | June 30, 2025 | FANGER, NEIL A | reporter.nih.gov |
| Metabolic Regulation of Articular Cartilage and Joint Homeostasis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $2,949,056 | July 8, 2021 | June 30, 2027 | O'KEEFE, REGIS J | reporter.nih.gov |
| Optimizing the value of pain management in knee OA patients with comorbidities | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $2,947,711 | August 1, 2018 | March 31, 2029 | LOSINA, ELENA | reporter.nih.gov |
| Rheumatoid Arthritis-associated Parenchymal Lung Disease: Clinical and Molecular Phenotypes | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,937,551 | April 15, 2022 | March 31, 2027 | WASHKO, GEORGE R | reporter.nih.gov |
| Human Genetic Variation and Disease | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $2,936,758 | July 22, 2016 | June 30, 2027 | JORDE, LYNN | reporter.nih.gov |
| Knee Arthroplasty Activity Trial (KArAT) | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $2,935,459 | September 23, 2022 | August 31, 2027 | LOSINA, ELENA | reporter.nih.gov |
| Multi-Vendor Multi-Site Novel Accelerated MRI Relaxometry | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $2,931,322 | May 1, 2020 | April 30, 2027 | LI, XIAOJUAN | reporter.nih.gov |
| NOVEL METABOLITE AND MICROBIOTA PATHWAYS FOR HYPERURICEMIA AND GOUT | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $2,924,301 | September 20, 2013 | February 28, 2027 | CHOI, HYON K | reporter.nih.gov |
| A Novel Immunologically Enhanced Probiotic for Treating Rheumatoid Arthritis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $2,922,693 | February 23, 2021 | January 31, 2025 | FANGER, GARY | reporter.nih.gov |
| Molecular Pathways of Pain Generation in Osteoarthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $2,896,087 | February 1, 2011 | June 30, 2026 | MALFAIT, ANNE-MARIE | reporter.nih.gov |
| The role of cytotoxic T cells in rheumatoid arthritis pathogenesis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $2,877,343 | September 1, 2021 | August 31, 2026 | ANDRADE, FELIPE | reporter.nih.gov |
| The mechanistic control of bone quality and joint crosstalk by osteocytes | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2024 | $2,877,278 | March 20, 2009 | May 31, 2026 | HERNANDEZ, CHRISTOPHER JOHN | reporter.nih.gov |
| Cannabinoid interactions with central and peripheral pain mechanisms in osteoarthritis of the knee | NIH | National Center for Complementary & Integrative Health | 2021 to 2024 | $2,864,374 | August 1, 2020 | May 31, 2026 | HARTE, STEVEN EDWARD | reporter.nih.gov |
| TLR7 and TLR9-directed plasma cell formation: Dissecting the molecular basis for their differential dependence on IFN-induced signals | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,853,080 | July 10, 2020 | June 30, 2026 | LUND, FRANCES E. | reporter.nih.gov |
| Molecular Determinants of Usual Interstitial Pneumonia (UIP) | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,826,957 | April 1, 2022 | March 31, 2027 | SCHWARTZ, DAVID ALBERT | reporter.nih.gov |
| Rheumatoid Arthritis and the Risk of Cardiovascular Disease: Biomarkers Risk Prediction and Underlying Mechanisms | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,807,438 | June 15, 2022 | May 31, 2027 | SOLOMON, DANIEL HAL | reporter.nih.gov |
| Monitoring Disease in Lupus | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $2,798,512 | March 8, 2019 | June 30, 2029 | MOHAN, CHANDRA | reporter.nih.gov |
| Defining the influence of RA genetic susceptibility factors on T cell antigen specificity and functional state | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $2,784,187 | August 2, 2013 | March 31, 2026 | RAYCHAUDHURI, SOUMYA | reporter.nih.gov |
| Simultaneous Imaging of Tissue Biochemistry and Metabolism associated with Biomechanics in Patella Femoral Joint Osteoarthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $2,778,600 | March 15, 2022 | February 28, 2027 | SOUZA, RICHARD BRIAN | reporter.nih.gov |
| NF-kappaB and Mitochondrial Signals as Positive and Negative Regulators of Inflammation | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,777,000 | June 1, 2023 | November 30, 2025 | KARIN, MICHAEL | reporter.nih.gov |
| Understanding the mechanisms by which weight change affects progression of knee osteoarthritis in obese and overweight individuals: An analysis of the Osteoarthritis Initiative Dataset | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $2,775,126 | April 1, 2021 | October 31, 2026 | LINK, THOMAS M | reporter.nih.gov |
| Ultra-Fast Knee MRI with Deep Learning | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $2,771,921 | April 1, 2021 | March 31, 2027 | MAJUMDAR, SHARMILA | reporter.nih.gov |
| FoxO transcription factors in joint aging and osteoarthritis pathogenesis | NIH | National Institute on Aging | 2021 to 2025 | $2,771,759 | May 15, 2018 | May 31, 2028 | LOTZ, MARTIN K | reporter.nih.gov |
| Supramolecular biomaterials for tuning the inflammatory properties of the complement system | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,759,425 | June 1, 2022 | May 31, 2027 | COLLIER, JOEL H | reporter.nih.gov |
| The Role of Creb5 in Maintaining Synovial Joint Homeostasis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $2,724,113 | July 28, 2022 | May 31, 2027 | LASSAR, ANDREW BRUCE | reporter.nih.gov |
| Bridging clinical trial and real-world data via machine learning to advance rheumatoid arthritis treatment strategies | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $2,718,736 | July 1, 2022 | June 30, 2027 | LIAO, KATHERINE PHOENIX | reporter.nih.gov |
| The IL-23/IL-17 Axis in Inflammatory Arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $2,710,108 | June 1, 2021 | November 30, 2026 | LEVY, DAN | reporter.nih.gov |
| Macrophage Heterogeneity in Rheumatoid Arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $2,660,867 | April 15, 2022 | February 28, 2027 | WINTER, DEBORAH RACHELLE | reporter.nih.gov |
| Role of GRAIL in B cell tolerance and B-cell mediated inflammation | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $2,630,572 | August 1, 2025 | July 31, 2029 | NURIEVA, ROZA INSAFETDINOVNA | reporter.nih.gov |
| Establishing a Single-Cell Proteomic Atlas for Normal and Osteoarthritic Articular Cartilage | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $2,626,425 | May 17, 2021 | March 31, 2026 | BHUTANI, NIDHI | reporter.nih.gov |
| Image-guided, robot-assisted reduction of joint dislocation in orthopaedic surgery | NIH | National Institute of Biomedical Imaging and Bioengineering | 2021 to 2024 | $2,590,549 | September 1, 2021 | May 31, 2026 | UNERI, ALI | reporter.nih.gov |
| Multi-modal Tracking of In Vivo Skeletal Structures and Implants | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2024 | $2,582,151 | April 15, 2022 | March 31, 2026 | CRISCO, JOSEPH J | reporter.nih.gov |
| Rapid Low-Cost Quantitative 3D MRI and Gait Assessment of the Knee | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2024 | $2,579,635 | August 15, 2020 | June 30, 2025 | HARGREAVES, BRIAN ANDREW | reporter.nih.gov |
| Micro-TeACH (Microbiome Technology and Analytic Center Hub) | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $2,568,320 | March 10, 2022 | December 31, 2026 | SCHER, JOSE U. | reporter.nih.gov |
| Bioinspired Mechanically Stiff Hydrogels for Osteochondral Tissue Regeneration | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $2,563,338 | July 25, 2016 | March 31, 2027 | BRYANT, STEPHANIE J | reporter.nih.gov |
| The Use of Senolytic and Anti-Fibrotic Agents to Improve the Beneficial Effect of Bone Marrow Stem Cells for Osteoarthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2024 | $2,563,053 | August 1, 2020 | July 31, 2025 | HUARD, JOHNNY | reporter.nih.gov |
| Role of ZBP1 in pathogenesis of Salmonella biofilms | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,527,208 | May 11, 2023 | April 30, 2028 | BALACHANDRAN, SIDDHARTH | reporter.nih.gov |
| Reducing Perioperative Oxidative Stress to Prevent Postoperative Chronic Pain Following Total Knee Arthroplasty | NIH | National Institute on Aging | 2025 | $2,526,074 | September 30, 2023 | August 31, 2028 | BRUEHL, STEPHEN | reporter.nih.gov |
| Immunologic Mechanisms and Rheumatic Diseases | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $2,525,449 | July 1, 1985 | July 31, 2030 | GRAVALLESE, ELLEN M | reporter.nih.gov |
| Web-based Pain Coping Skills Training to Improve Pain and Poor Adherence caused by Aromatase Inhibitor-Associated Arthralgia In Breast Cancer Survivors (SKIP-Arthralgia): A Randomized Controlled Trial | NIH | National Cancer Institute | 2022 to 2025 | $2,513,680 | June 1, 2022 | May 31, 2027 | RINI, CHRISTINE | reporter.nih.gov |
| Neural and Energetic Drivers of Performance and Perceived Fatigability in Older Adults | NIH | National Institute on Aging | 2022 to 2025 | $2,501,429 | September 15, 2022 | May 31, 2027 | ROSANO, CATERINA | reporter.nih.gov |
| A Mobile Health Behavior Intervention to Reduce Pain and Improve Health-III (MORPH-III) | NIH | National Institute on Aging | 2024 to 2025 | $2,500,587 | September 15, 2024 | August 31, 2029 | FANNING, JASON | reporter.nih.gov |
| Continuation Application for the development of Integrated continuous and single-use (ICS) bioproduction platform (Phase IIB) | NIH | National Institute of General Medical Sciences | 2022 to 2023 | $2,495,306 | January 1, 2016 | March 31, 2024 | SHINKAZH, OLEG | reporter.nih.gov |
| Treatment of Knee Osteoarthritis via Intra-articular Delivery of an Immunosuppressive Enzyme | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $2,493,979 | April 1, 2022 | March 31, 2027 | ALLEN, KYLE D | reporter.nih.gov |
| Integrative Omics analysis of human cartilage in aging and osteoarthritis | NIH | National Institute on Aging | 2021 to 2024 | $2,482,844 | January 15, 2016 | May 31, 2026 | LOTZ, MARTIN K | reporter.nih.gov |
| Deciphering multi-scale differentiation and patterning cues driving whole craniofacial joint regeneration | NIH | National Institute of Dental & Craniofacial Research | 2022 to 2025 | $2,462,001 | September 6, 2022 | August 31, 2027 | SMEETON, JOANNA MARJORIE | reporter.nih.gov |
| A Novel Immunological-Directed Biotherapy for Treating Rheumatoid Arthritis | NIH | National Institute on Aging | 2023 to 2025 | $2,434,680 | September 4, 2023 | June 30, 2027 | FANGER, GARY | reporter.nih.gov |
| Rapid Quantitative Assessment of Knee Joint with Compressed Sensing | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2024 | $2,428,622 | August 3, 2020 | July 31, 2026 | REGATTE, RAVINDER | reporter.nih.gov |
| Integrative analysis of high dimensional tissue molecular data to define key biological systems in autoimmune diseases (SBC) | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $2,419,724 | March 18, 2022 | December 31, 2026 | RAYCHAUDHURI, SOUMYA | reporter.nih.gov |
| CaMKK2 Signaling in Osteoarthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2024 | $2,408,999 | March 13, 2020 | January 31, 2026 | SANKAR, UMA | reporter.nih.gov |
| The Effects of Visit Characteristics on Patient-Clinician Interactions and Health Outcomes in Knee Osteoarthritis | NIH | National Institute on Aging | 2023 to 2025 | $2,402,726 | September 1, 2023 | June 30, 2028 | DOSSETT, MICHELLE L | reporter.nih.gov |
| OpenSim Enhancements to Enable Computational Design of Personalized Treatments for Movement Impairments | NIH | National Institute of Biomedical Imaging and Bioengineering | 2021 to 2024 | $2,391,188 | September 6, 2021 | May 31, 2026 | FREGLY, BENJAMIN J | reporter.nih.gov |
| Demographic Distribution of Hand Joint Space | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2022 | $2,373,086 | September 27, 2021 | August 31, 2024 | KWOH, C KENT | reporter.nih.gov |
| Regulation of Intracellular Signaling | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $2,370,356 | June 1, 2019 | February 28, 2029 | IIJIMA, MIHO | reporter.nih.gov |
| Deconstructing Cartilage Mechanotransduction by Piezo Channels | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2024 | $2,369,902 | June 2, 2021 | July 31, 2025 | GUILAK, FARSHID | reporter.nih.gov |
| Enhancing modulation Effect of Baduanjin through Non-invasive Neuromodulation for knee Osteoarthritis | NIH | National Center for Complementary & Integrative Health | 2023 to 2025 | $2,363,880 | August 4, 2023 | May 31, 2028 | KONG, JIAN | reporter.nih.gov |
| Post-Initiation control of transcription in inflammatory macrophages | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,363,024 | December 23, 2019 | November 30, 2025 | ROGATSKY, INEZ | reporter.nih.gov |
| Diet Interventions: Remitted and Evaluated as Complementary Treatments for Pain (DIRECTPain) | NIH | National Institute of Nursing Research | 2022 to 2025 | $2,358,097 | September 21, 2022 | June 30, 2027 | SORGE, ROBERT | reporter.nih.gov |
| Imaging of Joint Response to Physiological Stress with Age, Sex and in Osteoarthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $2,351,319 | May 1, 2022 | February 28, 2027 | KOGAN, FELIKS | reporter.nih.gov |
| Role of human innate immune mutations in loss of tolerance to Borrelia burgdorferi | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,344,769 | September 8, 2020 | August 31, 2025 | HU, LINDEN T | reporter.nih.gov |
| Transcriptional control of growth plate chondrocytes | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $2,317,204 | May 15, 2022 | April 30, 2027 | LEFEBVRE, VERONIQUE M | reporter.nih.gov |
| Identification of key regulators in rheumatoid arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2024 | $2,309,449 | August 1, 2014 | April 30, 2026 | WANG, WEI | reporter.nih.gov |
| MASPs as therapeutic targets in complement-mediated diseases | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,302,777 | March 18, 2020 | February 28, 2025 | SONG, WENCHAO | reporter.nih.gov |
| Joint Pain on a Chip: Mechanistic Analysis Therapeutic Targets and an Empirical Strategy for Personalized Pain Management | NIH | National Center for Advancing Translational Sciences | 2021 | $2,287,391 | September 26, 2019 | July 31, 2025 | GOLD, MICHAEL S | reporter.nih.gov |
| Establishing the Guma' Tinemtom to support population health research through island wisdom in Guam | NIH | National Institute on Minority Health and Health Disparities | 2022 to 2025 | $2,265,237 | July 1, 2022 | March 31, 2027 | PAULINO, YVETTE C | reporter.nih.gov |
| Move and Snooze: Adding insomnia treatment to an exercise program to improve pain outcomes in older adults with knee osteoarthritis | NIH | National Institute on Aging | 2023 to 2025 | $2,261,590 | September 30, 2023 | June 30, 2028 | WHIBLEY, DANIEL | reporter.nih.gov |
| Cell Senescence Regulating Osteoarthritis Progression: Sex-dependent Mechanisms | NIH | National Institute on Aging | 2023 to 2025 | $2,244,684 | January 15, 2023 | November 30, 2027 | CHEN, QIAN | reporter.nih.gov |
| Arthroscopic Raman Monitoring of Cartilage Content for PTOA Diagnosis and Chondroregenerative Treatment Response | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $2,239,693 | August 2, 2022 | May 31, 2027 | ALBRO, MICHAEL B | reporter.nih.gov |
| Leveraging Community-Academic Partnerships and Social Networks to Disseminate Vaccine-Related Information and Increase Vaccine Uptake Among Black Individuals with Rheumatic Diseases | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2024 | $2,239,160 | May 10, 2022 | April 1, 2025 | RAMSEY-GOLDMAN, ROSALIND | reporter.nih.gov |
| Roles of Collagen and Water in the Fracture Resistance of Bone | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $2,220,473 | September 1, 2012 | May 31, 2027 | NYMAN, JEFFRY STEPHEN | reporter.nih.gov |
| Development of a metabolomics and machine learning based high-throughput screening platform for data-driven drug discovery | NIH | National Institute of General Medical Sciences | 2021 to 2022 | $2,207,584 | September 1, 2018 | January 31, 2024 | BORDBAR, AARASH | reporter.nih.gov |
| Interpretation and Utility of Novel Composite Structural Endpoints of Cumulative Damage and Disease Activity in Knee Osteoarthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 to 2025 | $2,206,921 | January 23, 2024 | May 31, 2026 | DRIBAN, JEFFREY B | reporter.nih.gov |
| Immunologic and Clinical Sequelae after COVID-19 in Patients with Systemic Autoimmune Rheumatic Diseases | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 to 2025 | $2,205,056 | February 1, 2023 | January 31, 2028 | SPARKS, JEFFREY ANDREW | reporter.nih.gov |
| Promoting regenerative repair of aged cartilage | NIH | National Institute on Aging | 2023 to 2025 | $2,189,662 | May 15, 2023 | January 31, 2028 | COLLINS, JOHN A | reporter.nih.gov |
| Modification of Post-Traumatic Osteoarthritis Progression with Joint Unloading | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2024 | $2,182,992 | March 1, 2020 | November 30, 2025 | CHRISTIANSEN, BLAINE A. | reporter.nih.gov |
| Digital Biomarkers of Post-traumatic Osteoarthritis: Toward Precision Rehabilitation | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $2,179,833 | September 1, 2022 | August 31, 2027 | HALILAJ, ENI | reporter.nih.gov |
| Probing Osteoarthritis Pathogenesis by Noninvasive Imaging of Cartilage Strain | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2023 | $2,176,180 | September 19, 2013 | March 31, 2025 | NEU, COREY P | reporter.nih.gov |
| Targeting angiogenesis for fracture nonunion treatment under inflammatory diseases | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $2,165,056 | September 9, 2020 | June 30, 2027 | SHEN, JIE | reporter.nih.gov |
| Pathogenesis of Systemic Juvenile Idiopathic Arthritis-Associated Lung Disease | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $2,153,155 | April 6, 2022 | February 28, 2027 | SCHULERT, GRANT SANFORD | reporter.nih.gov |
| Identifying a novel pathway that regulates RA immunometabolism | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,137,878 | July 8, 2022 | June 30, 2028 | SHAHRARA, SHIVA | reporter.nih.gov |
| Tissue Adhesive RNA Interference Nanoparticles to Block Progression of Posttraumatic and Spontaneous Osteoarthritis. | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $2,136,077 | August 22, 2022 | July 31, 2027 | DUVALL, CRAIG LEWIS | reporter.nih.gov |
| Improvement of Animal Models for TMJ Stem Cell-Based Regeneration | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2023 | $2,135,816 | July 15, 2019 | April 30, 2025 | EMBREE, MILDRED CHRISTINE | reporter.nih.gov |
| A Bio-inspired Latent TGF-beta Conjugated Scaffold for Patient-specific Cartilage Regeneration | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $2,133,303 | June 1, 2022 | May 31, 2027 | ALBRO, MICHAEL B | reporter.nih.gov |
| Suppressing Inflammation by Blocking IKK Oligomer | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,117,232 | February 15, 2022 | January 31, 2027 | GHOSH, GOURISANKAR | reporter.nih.gov |
| Data-Driven Learning Framework for Fast Quantitative Knee Joint Mapping | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $2,115,033 | July 1, 2021 | May 31, 2027 | WUST ZIBETTI, MARCELO VICTOR | reporter.nih.gov |
| Neural immunoregulation of post-traumatic autoimmunity | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $2,111,177 | September 1, 2016 | July 31, 2027 | KINGERY, WADE S | reporter.nih.gov |
| Academic Rheumatology and Clinical Immunology | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $2,110,183 | June 1, 2021 | May 31, 2026 | ZIKHERMAN, JULIE | reporter.nih.gov |
| Investigating monocyte dysfunction in Down Syndrome | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2023 | $2,109,849 | July 24, 2019 | December 31, 2024 | HAMERMAN, JESSICA A | reporter.nih.gov |
| Novel approaches to promote healing of bone loss in inflammatory arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $2,084,763 | March 14, 2022 | February 28, 2027 | SHIM, JAE-HYUCK | reporter.nih.gov |
| Intra-cartilage depot delivery of electrically-charged IL-1RA for targeting osteoarthritis-associated inflammation and catabolism in multiple joint tissues | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $2,062,254 | September 21, 2020 | July 31, 2026 | BAJPAYEE, AMBIKA GOEL | reporter.nih.gov |
| Engineered probiotic for the treatment of autoimmune diseases | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,050,291 | March 20, 2023 | February 29, 2028 | BEETON, CHRISTINE | reporter.nih.gov |
| Multinuclear MRI to Assess Joint Homeostasis after Knee Injury | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $2,048,056 | July 1, 2022 | November 30, 2027 | MADELIN, GUILLAUME | reporter.nih.gov |
| Brain Pathophysiology of Osteoarthritis Pain | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2023 | $2,046,367 | February 1, 2019 | December 31, 2024 | APKARIAN, APKAR VANIA | reporter.nih.gov |
| Neural Ice Technology for Treatment of Pain | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 to 2025 | $2,045,816 | August 21, 2024 | July 31, 2027 | SIDOTI, CHARLES | reporter.nih.gov |
| Simulation and Education Tool for Physical Examinations of Orthopedic Pathologies | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2024 | $2,045,149 | July 1, 2022 | June 30, 2026 | CONDON, JOHN PAUL | reporter.nih.gov |
| Neutrophil Extracellular Traps in the Lung and Development of Rheumatoid Arthritis-Related Autoimmunity and Arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2024 | $2,044,363 | February 7, 2020 | January 31, 2026 | DEMORUELLE, M. KRISTEN | reporter.nih.gov |
| Subchondral Trabecular Plate and Rod Abnormalities in Human Osteoarthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 to 2025 | $2,030,282 | June 1, 2023 | May 31, 2028 | GUO, X. EDWARD | reporter.nih.gov |
| Genomic and Imaging Markers to Understand and Predict Progression of Joint Damage After Injury | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 to 2025 | $2,029,292 | August 8, 2023 | July 31, 2028 | KIRSCH, THORSTEN | reporter.nih.gov |
| Sustained Biomaterial-mediated Inhibition of R-spondin 2 to Target Pathological Wnt Signaling in Post-Traumatic Osteoarthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $2,029,238 | September 15, 2022 | June 30, 2027 | HANKENSON, KURT DAVID | reporter.nih.gov |
| Age-related decline in endogenous pain modulation and its impact on osteoarthritis pain | NIH | National Institute on Aging | 2022 to 2025 | $2,028,372 | June 1, 2022 | March 31, 2027 | RO, JIN Y | reporter.nih.gov |
| Immunobiology of the Rheumatic Diseases | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $2,027,343 | September 30, 1977 | July 31, 2027 | LENSCHOW, DEBORAH J | reporter.nih.gov |
| Brain-based and clinical phenotyping of pain pharmacotherapy in knee OA | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 to 2025 | $2,020,563 | August 15, 2023 | July 31, 2028 | SCHNITZER, THOMAS JACK | reporter.nih.gov |
| Intra-articular corticosteroid injections for symptomatic osteoarthritis: The effects of injection dose, frequency, and timing on safety | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2025 | $2,017,972 | September 10, 2025 | August 31, 2028 | BUTLER, ANNE MOBLEY | reporter.nih.gov |
| Non-SteroidAl Impact on Kidney Disease Study (NSAIDS) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $2,009,118 | May 15, 2023 | March 31, 2028 | ESTRELLA, MICHELLE M | reporter.nih.gov |
| Revision ACL Reconstruction: A Comparative Effectiveness Treatment Study | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $2,009,015 | September 1, 2011 | August 30, 2029 | WRIGHT, RICK W | reporter.nih.gov |
| Elucidation of the Role of Creb5 in Synovial Joint Formation | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2024 | $2,004,843 | September 18, 2019 | May 9, 2025 | LASSAR, ANDREW BRUCE | reporter.nih.gov |
| Transcriptional Checkpoints Of Autoimmune Encephalomyelitis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,003,720 | December 20, 2019 | November 30, 2025 | JORDAN, MARTHA S | reporter.nih.gov |
| Commercialization Readiness Pilot (CRP) program support for: Ultra-sensitive, direct-from-blood, molecular detection of Borrelia infections. | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $2,000,000 | April 2, 2024 | March 31, 2027 | SINGER, ALON | reporter.nih.gov |
| Augmented Reality Platform for Telehealth Rehabilitation | NIH | National Institute on Aging | 2023 to 2025 | $1,998,221 | June 1, 2021 | October 31, 2026 | SHIWANI, BHAWNA | reporter.nih.gov |
| The Study of Muscle, Mobility and Aging with Knee OA | NIH | National Institute on Aging | 2021 to 2025 | $1,995,873 | September 1, 2021 | May 31, 2027 | LANE, NANCY E | reporter.nih.gov |
| The Role of Mechanosensation Pathways in Osteoarthritis Joint Damage and Pain | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $1,990,517 | April 2, 2021 | August 31, 2026 | MILLER, RACHEL ELIZABETH | reporter.nih.gov |
| Evaluation of mechanistic role of artemin/GFRα3 signaling in osteoarthritis pain | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2024 | $1,988,920 | May 1, 2022 | April 30, 2028 | MISHRA, SANTOSH K. | reporter.nih.gov |
| Influence of bacterial tryptophan metabolism on inflammatory arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $1,982,751 | April 10, 2019 | July 31, 2029 | KUHN, KRISTINE A. | reporter.nih.gov |
| Advancing Hemiarthroplasty: Predicting in vivo performance of cartilage bearing systems through benchtop and ex vivo testing. | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 to 2025 | $1,979,272 | August 15, 2023 | July 31, 2028 | CRISCO, JOSEPH J | reporter.nih.gov |
| Molecular mechanisms of Salmonella mediated autoimmunity | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $1,975,400 | June 1, 2020 | May 31, 2025 | TUKEL, CAGLA | reporter.nih.gov |
| Development of an automated IVD for the ultra-sensitive, direct, molecular detection of Borrelia for early Lyme Disease | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $1,972,995 | June 15, 2020 | May 31, 2024 | SINGER, ALON | reporter.nih.gov |
| Novel functions of Thrombin Activatable Fibrinolysis Inhibitor (TAFI) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,967,120 | April 1, 2020 | July 31, 2024 | MOSNIER, LAURENT OLIVIER | reporter.nih.gov |
| Targeting the CCR6-CCL20 pathway for treatment of psoriatic joint and entheseal inflammation | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 to 2024 | $1,964,807 | September 1, 2023 | August 31, 2025 | CLARKE, WILLIAM R | reporter.nih.gov |
| Employing the gut microbiome to accelerate effective initiation of rheumatoid arthritis therapy | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2023 | $1,960,579 | September 1, 2019 | August 31, 2025 | SCHER, JOSE U. | reporter.nih.gov |
| Role of the CD47 Pathway in Rheumatoid Arthritis Pathogenesis and Treatment | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $1,960,562 | September 20, 2022 | July 31, 2027 | KORMAN, BENJAMIN DOUGLAS | reporter.nih.gov |
| Biopsychosocial determinants of pediatric-onset chronic musculoskeletal pain | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2025 | $1,955,201 | September 19, 2025 | July 31, 2030 | KASHIKAR-ZUCK, SUSMITA | reporter.nih.gov |
| Rapid quantification of nuclear citrullination in human neutrophils | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $1,952,315 | June 13, 2018 | January 31, 2023 | JOHNSTONE, ANDREA LYNN | reporter.nih.gov |
| Identifying novel osteoarthritis risk genes using GWAS, chondrocyte genomics, and genome editing | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $1,950,418 | September 20, 2022 | August 31, 2027 | PHANSTIEL, DOUGLAS H. | reporter.nih.gov |
| Cellular Stress in Pain and Tissue Damage | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2025 | $1,950,412 | September 10, 2025 | August 31, 2028 | ROMERO-SANDOVAL, E. ALFONSO | reporter.nih.gov |
| Phlpp phosphatases in osteoarthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $1,935,825 | September 21, 2022 | August 31, 2027 | WESTENDORF, JENNIFER J | reporter.nih.gov |
| Cytokine regulation of RA synoviocyte phenotype | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $1,930,588 | September 27, 1999 | May 31, 2027 | IVASHKIV, LIONEL B | reporter.nih.gov |
| Sialylation of TLR2 Induces Osteoclast Fusion and Th 17 differentiation During Aging | NIH | National Institute on Aging | 2022 to 2025 | $1,926,073 | July 1, 2022 | March 31, 2027 | CAO, XU | reporter.nih.gov |
| Role of DNA damage and cellular senescence in osteoarthritis pathophysiology | NIH | National Institute on Aging | 2023 to 2025 | $1,923,686 | September 30, 2023 | May 31, 2028 | DIEKMAN, BRIAN O | reporter.nih.gov |
| Molecular pathways of calcium pyrophosphate deposition disease | NIH | National Institute on Aging | 2022 to 2025 | $1,916,779 | September 1, 2022 | May 31, 2027 | ROSENTHAL, ANN K | reporter.nih.gov |
| In Vivo Knee Motion and ACL Biomechanics During Dynamic Activities | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2024 | $1,913,305 | May 1, 2014 | July 31, 2025 | DEFRATE, LOUIS E. | reporter.nih.gov |
| Research Training in Rheumatology at Massachusetts General Hospital | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $1,901,968 | July 1, 1977 | June 30, 2029 | LUSTER, ANDREW D | reporter.nih.gov |
| Dysregulation of epidermal innate immune signaling as driver of Psoriatic-like arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2025 | $1,901,310 | September 15, 2025 | August 31, 2028 | RAZANI, BAHRAM | reporter.nih.gov |
| B cell costimulatory signals in the pathogenesis of SLE | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2023 | $1,899,404 | August 1, 2019 | June 30, 2024 | JACKSON, SHAUN WILLIAM | reporter.nih.gov |
| Effects of TNF Blockade on Human BPH/LUTS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $1,899,179 | August 15, 2023 | May 31, 2028 | HAYWARD, SIMON W | reporter.nih.gov |
| Optimizing Ultrasound Regimens for Achieving Cartilage Repair | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $1,896,387 | February 11, 2022 | November 30, 2026 | SUBRAMANIAN, ANURADHA | reporter.nih.gov |
| Improving COVID-19 Vaccine Uptake Among Racial and Ethnic Minority Groupswith Rheumatic Diseases | NIH | National Institute on Minority Health and Health Disparities | 2023 to 2025 | $1,876,437 | August 17, 2023 | May 31, 2028 | DANILA, MARIA IOANA | reporter.nih.gov |
| A self-assembled hydrogel with tunable drug release kinetics for preventing osteoarthritis in active joints | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $1,875,630 | May 1, 2021 | March 31, 2027 | JOSHI, NITIN | reporter.nih.gov |
| Combination Gene Therapy for Treatment of Canine Mucopolysaccharidosis Type I | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2025 | $1,867,960 | May 5, 2023 | February 29, 2028 | WANG, RAYMOND YU JEANG | reporter.nih.gov |
| Regulation of T helper cell functions by aryl hydrocarbon receptor | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $1,865,873 | May 18, 2021 | March 31, 2026 | RAO, DEEPAK ANGARA | reporter.nih.gov |
| Predicting uveitis onset in children with juvenile idiopathic arthritis | NIH | National Eye Institute | 2021 to 2023 | $1,863,787 | September 30, 2019 | June 30, 2025 | ANGELES-HAN, SHEILA THERESE | reporter.nih.gov |
| Cartilage Regeneration with Tunable Inflammation Resistance | NIH | National Institute on Aging | 2021 to 2023 | $1,862,105 | September 15, 2017 | May 31, 2026 | ESTES, BRADLEY T | reporter.nih.gov |
| Improved Diagnostic MRI around Metallic Implants | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2024 | $1,852,226 | February 1, 2022 | December 31, 2027 | NAYAK, KRISHNA S | reporter.nih.gov |
| PARTIAL MENISCECTOMY VS. NONOPERATIVE MGMT. IN MENISCAL TEAR WITH OA: AN RCT | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2023 | $1,851,873 | September 21, 2007 | August 31, 2025 | KATZ, JEFFREY NEIL | reporter.nih.gov |
| Nonaddictive opioid prodrug nanomedicine for musculoskeletal pain | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $1,851,532 | September 7, 2022 | July 31, 2027 | WANG, DONG | reporter.nih.gov |
| Defining the molecular and radiologic phenotype of progressive RA-ILD | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,845,758 | August 1, 2023 | May 31, 2028 | LEE, JOYCE SUJIN | reporter.nih.gov |
| Hyaluronan signaling to nociceptors in inflammatory pain | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2023 | $1,845,667 | April 5, 2019 | January 31, 2024 | LEVINE, JON DAVID | reporter.nih.gov |
| Knee-Biofeedback Rehabilitation Interface for Game-based Home Therapy (KneeBRIGHT) | NIH | National Institute on Aging | 2023 to 2024 | $1,836,814 | September 30, 2018 | November 30, 2025 | KREPKOVICH, EILEEN T. | reporter.nih.gov |
| STABILITY 2: ACL Reconstruction +/- Lateral Tenodesis with Patellar vs. Quad Tendon | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $1,826,074 | September 17, 2019 | February 28, 2026 | IRRGANG, JAMES JOHN | reporter.nih.gov |
| Reducing Perioperative Oxidative Stress to Prevent Postoperative Chronic Pain Following Total Knee Arthroplasty | NIH | National Institute on Aging | 2023 to 2024 | $1,823,768 | September 30, 2023 | August 31, 2028 | BRUEHL, STEPHEN | reporter.nih.gov |
| Training Program/Rheumatic Diseases | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $1,820,037 | May 1, 2020 | May 31, 2030 | MERKEL, PETER A | reporter.nih.gov |
| Defining the Pathogenic Contribution of High Genotypic MIF Expression | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $1,816,705 | June 1, 2021 | April 30, 2026 | BUCALA, RICHARD J | reporter.nih.gov |
| Translational strategies for optimizing musculoskeletal recovery after ACL injury | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $1,813,356 | August 15, 2022 | May 31, 2027 | LEPLEY, LINDSEY K | reporter.nih.gov |
| Cell-directed gene therapy for pain recovery after surgery and inflammation | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $1,809,441 | January 15, 2022 | December 31, 2026 | ROMERO-SANDOVAL, E. ALFONSO | reporter.nih.gov |
| Self-Powered Load Sensors for Total Knee Replacement Health Monitoring | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $1,805,455 | June 1, 2022 | May 31, 2027 | TOWFIGHIAN, SHAHRZAD | reporter.nih.gov |
| Brain neural networks regulating inflammation | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 to 2025 | $1,802,946 | September 18, 2023 | August 31, 2028 | TRACEY, KEVIN J | reporter.nih.gov |
| Collagen-mediated approaches to improve the local delivery and hypothermic release of osteoarthritis therapeutics | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 to 2025 | $1,801,687 | September 1, 2023 | July 31, 2028 | KIICK, KRISTI L | reporter.nih.gov |
| EGFR signaling in osteoarthritis and treatment | NIH | National Institute on Aging | 2021 to 2024 | $1,794,940 | September 30, 2020 | June 30, 2025 | QIN, LING | reporter.nih.gov |
| Morphological and Biomechanical Insights into the Pathophysiology of Femoroacetabular Impingement Syndrome | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $1,794,039 | July 1, 2020 | June 30, 2027 | ANDERSON, ANDREW EDWARD | reporter.nih.gov |
| Mechanistic Pharmacokinetics and Pharmacodynamics | NIH | National Institute of General Medical Sciences | 2021 to 2023 | $1,792,910 | May 1, 2019 | April 30, 2025 | JUSKO, WILLIAM J. | reporter.nih.gov |
| Endogenous retrovirus in joint aging and osteoarthritis development | NIH | National Institute on Aging | 2023 to 2025 | $1,791,833 | August 15, 2023 | April 30, 2028 | YANG, TAO | reporter.nih.gov |
| Genetic and Genomic Dissection of Psoriatic Arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2023 | $1,790,366 | September 12, 2012 | June 30, 2025 | ELDER, JAMES TILFORD | reporter.nih.gov |
| Intra-Articular Drug Delivery Modulating Immune Cells in Inflammatory Joint Disease | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 to 2025 | $1,782,728 | February 1, 2023 | December 31, 2028 | ZHANG, LIANGFANG | reporter.nih.gov |
| Macrophages in human autoimmune tissue pathology | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $1,780,000 | May 4, 2020 | April 30, 2026 | DONLIN, LAURA T. | reporter.nih.gov |
| Regulation of chondrocyte fate and function by ECM Viscoelasticity | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 to 2025 | $1,772,780 | September 1, 2023 | June 30, 2028 | BHUTANI, NIDHI | reporter.nih.gov |
| Translational genomics in gout: From GWAS signal to mechanism | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 to 2025 | $1,771,754 | September 21, 2023 | August 31, 2028 | MERRIMAN, TONY R | reporter.nih.gov |
| Training Program in Investigative Rheumatology | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $1,767,957 | July 1, 1976 | August 31, 2026 | BUCALA, RICHARD J | reporter.nih.gov |
| Carpometacarpal Osteoarthritis: Understanding the Intersection of Muscle Mechanics, Joint Instability, and Pain | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $1,766,845 | April 1, 2022 | March 31, 2027 | NICHOLS, JENNIFER A. | reporter.nih.gov |
| A Multisystem Resilience Approach in the Assessment of Postsurgical Pain Trajectories | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 to 2025 | $1,766,506 | September 14, 2023 | July 31, 2028 | BARTLEY, EMILY J. | reporter.nih.gov |
| Role of PTPRS in Rheumatoid Arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $1,765,973 | September 1, 2014 | March 31, 2027 | BOTTINI, NUNZIO | reporter.nih.gov |
| Effect of statin intake on Non-traumatic Generalized Knee Osteoarthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $1,765,770 | September 22, 2021 | August 31, 2026 | DEMEHRI, SHADPOUR | reporter.nih.gov |
| Molecular engineering of HA-based lubricants for articular cartilage | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 to 2025 | $1,761,424 | July 21, 2023 | June 30, 2028 | VARGHESE, SHYNI | reporter.nih.gov |
| Scientist Training in Rheumatology Research | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $1,757,460 | July 1, 1976 | June 30, 2028 | KNIGHT, JASON | reporter.nih.gov |
| Regulation of Osteoclastogenesis and Arthritic Bone Resorption by RBP-J | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $1,755,074 | April 1, 2017 | December 31, 2028 | ZHAO, BAOHONG | reporter.nih.gov |
| Cellular and humoral immunity in Lyme arthritis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $1,748,421 | January 8, 2019 | June 30, 2024 | STEERE, ALLEN C | reporter.nih.gov |
| Multi-Scale In Vitro 3D Tissue Model of Vascularized Bone-Cartilage Interactions | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2022 | $1,730,750 | September 21, 2017 | August 31, 2024 | ROEHM, KEVIN | reporter.nih.gov |
| MiACLR: Michigan Initiative for Anterior Cruciate Ligament Rehabilitation | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2023 | $1,730,414 | September 1, 2018 | December 31, 2024 | PALMIERI-SMITH, RIANN MARIE | reporter.nih.gov |
| Deep Learning Technology for Rapid Morphological and Quantitative Imaging of Knee Pathology | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $1,726,932 | June 1, 2022 | May 31, 2027 | LIU, FANG | reporter.nih.gov |
| Synovial Macrophage Transcriptional Signatures for Predicting Therapeutic Efficacy | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2023 | $1,724,874 | September 18, 2019 | July 31, 2025 | PERLMAN, HARRIS R | reporter.nih.gov |
| Research Training in Rheumatology | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $1,722,123 | July 1, 1975 | June 30, 2026 | MUSTELIN, TOMAS M | reporter.nih.gov |
| Treating knee osteoarthritis by sPLA2 inhibitor-loaded micellar nanoparticles | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $1,715,893 | April 1, 2022 | March 31, 2028 | CHENG, ZHILIANG | reporter.nih.gov |
| Preclinical Development of the TAK1 Inhibitor HS-276 for the Treatment of Rheumatoid Arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2022 | $1,709,883 | September 22, 2021 | August 31, 2024 | SCARNEO, SCOTT | reporter.nih.gov |
| Preoperative perturbation training to prevent falls after total knee arthroplasty | NIH | National Institute on Aging | 2022 to 2024 | $1,709,303 | September 1, 2022 | June 30, 2027 | FOUCHER, KHARMA CHARISSE | reporter.nih.gov |
| The impact of sex and gender on disease progression, from developmental origins | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $1,704,773 | September 10, 2020 | August 31, 2025 | PISARSKA, MARGARETA | reporter.nih.gov |
| Immune Checkpoint Inhibition and humoral immune response in systemic autoimmunity | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $1,697,982 | August 15, 2021 | February 28, 2027 | ZENG, HU | reporter.nih.gov |
| Quantitative bone radiomics using Ultra-High Resolution CT | NIH | National Institute of Biomedical Imaging and Bioengineering | 2021 to 2024 | $1,691,144 | July 1, 2021 | March 31, 2026 | ZBIJEWSKI, WOJCIECH BARTOSZ | reporter.nih.gov |
| ProGel Technology for Better Management of Osteoarthritis Pain | NIH | National Institute on Drug Abuse | 2021 to 2022 | $1,680,880 | May 1, 2020 | December 31, 2023 | GOLDRING, STEVEN | reporter.nih.gov |
| Randomized controlled trial evaluating an innovative community-based intervention combining group-based exercise and behavioral health skills-training for older adults with painful knee osteoarthritis | NIH | National Institute on Aging | 2021 to 2023 | $1,676,006 | May 1, 2019 | April 30, 2025 | PATEL, KUSHANG | reporter.nih.gov |
| Articular Cartilage Tissue Engineering with Human Pluripotent Stem Cells | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $1,673,298 | April 1, 2021 | March 31, 2027 | NAKAYAMA, NAOKI | reporter.nih.gov |
| Treatment and prevention of osteoarthritis with an intra-articular disease-modifying regenerative therapy | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2022 | $1,671,789 | September 16, 2021 | August 31, 2024 | ANGLE, SIDDHESH | reporter.nih.gov |
| Cell-Matrix Regulation of Fibrochondrocytes in TMJ OA | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2024 | $1,659,762 | April 1, 2021 | March 31, 2026 | REED, DAVID ANDREW | reporter.nih.gov |
| Effectiveness of the HPV Vaccine in Immunocompromised Populations | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,654,519 | July 9, 2024 | May 31, 2029 | SILVERBERG, MICHAEL J | reporter.nih.gov |
| Rapid Three-dimensional Simultaneous Knee Multi-Relaxation Mapping | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $1,652,212 | July 15, 2022 | May 31, 2027 | LIU, FANG | reporter.nih.gov |
| Biodegradable Piezoelectric Nanocomposite Scaffold with Physical Exercise to Heal Major Cartilage Defects in Large Animals | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $1,650,011 | June 3, 2022 | April 30, 2027 | NGUYEN, THANH | reporter.nih.gov |
| Assessment of ultrasound features of knee osteoarthritis in a population-based community cohort | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2024 | $1,642,059 | May 5, 2020 | April 30, 2025 | NELSON, AMANDA E | reporter.nih.gov |
| ROS scavenging nanoparticles for mitigating oxidative stress in osteoarthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 to 2025 | $1,641,378 | February 23, 2023 | January 31, 2029 | SHARMA, BLANKA | reporter.nih.gov |
| Modulation of Inflammation in Osteoarthritis via CD14-mediated pattern recognition | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $1,640,656 | August 1, 2020 | July 31, 2026 | SCANZELLO, CARLA ROSE | reporter.nih.gov |
| Elucidating the Mechanisms of Arthritic Flare and Developing Treatments | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $1,629,617 | August 15, 2009 | July 31, 2027 | SCHWARZ, EDWARD M. | reporter.nih.gov |
| Oxidative Stress and the Development of Osteoarthritis | NIH | National Institute on Aging | 2021 to 2025 | $1,625,347 | September 30, 2012 | February 29, 2028 | LOESER, RICHARD F | reporter.nih.gov |
| Advanced 7 Tesla imaging of the knee for root cause of Osteoarthritis | NIH | National Institute of Biomedical Imaging and Bioengineering | 2023 to 2025 | $1,623,129 | August 1, 2023 | July 31, 2027 | ELLERMANN, JUTTA M | reporter.nih.gov |
| Development of Injectable Super-Lubricious Microgels for Sustained Release of Platelet-Rich Plasma to Treat Post-Traumatic Osteoarthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 to 2025 | $1,619,642 | May 10, 2023 | March 31, 2028 | ZUSTIAK, SILVIYA PETROVA | reporter.nih.gov |
| Understanding A Molecular Cascade That Drives Neutrophil Mediated Pathology In Arthritis | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $1,618,172 | February 9, 2023 | January 31, 2028 | ARANDJELOVIC, SANJA | reporter.nih.gov |
| Deconstructing the molecular and cellular mechanisms of psoriatic arthritis pain by an improved animal model | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2025 | $1,617,503 | September 1, 2025 | August 31, 2028 | CHEN, YONG | reporter.nih.gov |
| Home-Based Leg Dexterity Trainer for Management of Knee Osteoarthritis | NIH | National Institute on Aging | 2024 to 2025 | $1,614,347 | September 25, 2024 | May 31, 2027 | VALERO, ERIKA | reporter.nih.gov |
| Patient-centered Development of a Composite Digital Endpoint of Mobility and Pain for Knee Osteoarthritis | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $1,614,289 | August 1, 2025 | July 31, 2027 | KUMAR, DEEPAK | reporter.nih.gov |
| Training Program in Adult and Pediatric Rheumatology | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $1,609,927 | May 1, 2005 | June 30, 2026 | LEWIS, DAVID BRAM | reporter.nih.gov |
| Central Sensitization and Sleep Disturbance as Predictors of Treatment Outcomes in Patients with Knee Osteoarthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2024 | $1,605,759 | August 1, 2021 | July 31, 2026 | CAMPBELL, CLAUDIA MICHELLE | reporter.nih.gov |
| DYNAMICS AND TUNING OF THE MHC II PRESENTED PEPTIDOME | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $1,603,685 | September 19, 2018 | August 31, 2025 | SANTAMBROGIO, LAURA | reporter.nih.gov |
| Ultrashort Echo Time Magnetic Resonance Imaging of Hemophilic Arthropathy | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2024 | $1,584,359 | April 6, 2021 | March 2, 2024 | JANG, HYUNGSEOK | reporter.nih.gov |
| Gene-environment interaction pathways in rheumatoid arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2023 | $1,581,271 | April 9, 2019 | February 28, 2025 | HOLOSHITZ, JOSEPH | reporter.nih.gov |
| Role of Glucose metabolism in Chondrocyte Mechanotransduction | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2024 | $1,576,819 | June 1, 2019 | February 28, 2026 | JUNE, RONALD KENT | reporter.nih.gov |
| Regenerative Rehabilitative Principles in Modulating Weight Bearing and Joint Kinematics to Delay Post-Traumatic Knee Osteoarthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $1,576,611 | April 1, 2022 | January 31, 2027 | TSAI, LIANG-CHING | reporter.nih.gov |
| Population-Based Outcomes Research for Rheumatoid Arthritis: Rural Health Disparities | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 to 2025 | $1,574,497 | September 24, 2024 | July 31, 2029 | CROWSON, CYNTHIA S | reporter.nih.gov |
| Molecular Genetics of Lyme Arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2024 | $1,567,371 | January 15, 2020 | November 30, 2025 | WEIS, JANIS J. | reporter.nih.gov |
| Epigenetic Regulation of Bone Regeneration in Inflammatory Disease | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2024 | $1,566,325 | July 8, 2019 | June 30, 2025 | SHEN, JIE | reporter.nih.gov |
| Rheumatic Diseases Research Training Grant | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $1,564,962 | May 15, 2013 | April 30, 2029 | GUMA, MONICA | reporter.nih.gov |
| Heme and Nonheme Transition Metal Complexes, Reactivity, and Mechanism | NIH | National Institute of General Medical Sciences | 2023 to 2025 | $1,563,157 | September 1, 2023 | August 31, 2028 | GOLDBERG, DAVID P | reporter.nih.gov |
| Targeting PHLPP to treat interval disc degeneration using surgical and drug delivery methods | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $1,562,670 | May 10, 2022 | April 30, 2027 | ILLIEN-JUNGER, SVENJA | reporter.nih.gov |
| Metabolic Biomarkers for Fibromyalgia | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2024 | $1,561,793 | September 1, 2020 | August 31, 2025 | SLUKA, KATHLEEN A | reporter.nih.gov |
| Morphologic and Kinematic Adaptations of the Subtalar Joint after Ankle Fusion Surgery in Patients with Varus-type Ankle Osteoarthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 to 2025 | $1,557,053 | September 12, 2023 | August 31, 2028 | ANDERSON, ANDREW EDWARD | reporter.nih.gov |
| Cytokine Balance in Rheumatoid Arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $1,542,904 | September 10, 2004 | January 31, 2027 | IVASHKIV, LIONEL B | reporter.nih.gov |
| Synovial lymphatics and osteoarthritis in aging | NIH | National Institute on Aging | 2021 to 2024 | $1,542,007 | January 1, 2020 | November 30, 2025 | XING, LIANPING | reporter.nih.gov |
| EMRSHN: Exploring the modulatory role of sex hormones along the neuromechanical axis in females | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2023 | $1,540,067 | September 1, 2016 | April 30, 2024 | DHAHER, YASIN YOUSEF | reporter.nih.gov |
| Immunological, serologic, and imaging biomarker predictors of flare in pediatric spondyloarthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $1,535,030 | September 20, 2021 | February 28, 2027 | WEISS, PAMELA FITCH | reporter.nih.gov |
| Role of protein citrullination in rheumatoid arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2024 | $1,526,019 | February 1, 2020 | December 31, 2024 | MUSTELIN, TOMAS M | reporter.nih.gov |
| Research Training in Rheumatology | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $1,525,211 | September 1, 1986 | August 31, 2027 | KUHN, KRISTINE A. | reporter.nih.gov |
| Disease Modifying Analgesia with CA8 Gene Therapy | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $1,516,241 | September 30, 2021 | September 15, 2023 | LEVITT, ROY C. | reporter.nih.gov |
| The Role of the Nociceptor Endocytosis in Inflammatory Pain | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $1,513,948 | June 15, 2022 | May 31, 2027 | BHATTACHARJEE, ARINDAM | reporter.nih.gov |
| Develop BCL-xL proteolysis targeting chimeras as safer and better senolytics | NIH | National Institute on Aging | 2021 to 2023 | $1,510,674 | August 1, 2019 | March 31, 2025 | ZHENG, GUANGRONG | reporter.nih.gov |
| Pathogenesis of Alphavirus induced Chronic Arthritis and Myositis | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,508,138 | June 11, 2024 | April 30, 2029 | LENSCHOW, DEBORAH J | reporter.nih.gov |
| Decipher and target GABA metabolism and GABA receptor-mediated signaling in autoimmune diseases | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $1,499,167 | February 10, 2023 | January 31, 2028 | WANG, RUONING | reporter.nih.gov |
| Role of Desumoylase SENP6 in Joint Aging and Osteoarthritis Development | NIH | National Institute on Aging | 2021 to 2023 | $1,495,470 | July 15, 2019 | September 30, 2025 | YANG, TAO | reporter.nih.gov |
| Trained innate immunity and periodontitis-associated comorbidities | NIH | National Institute of Dental & Craniofacial Research | 2022 to 2025 | $1,487,525 | February 1, 2022 | January 31, 2027 | HAJISHENGALLIS, GEORGIOS | reporter.nih.gov |
| Growth hormone regulating chondrocyte metabolism for osteoarthritis development | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 to 2025 | $1,486,776 | July 3, 2023 | May 31, 2028 | ZHU, SHOUAN | reporter.nih.gov |
| Translational Basic and Clinical Research Training in Rheumatology | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $1,479,519 | May 1, 2017 | May 31, 2027 | BUYON, JILL P | reporter.nih.gov |
| Unraveling Fundamental Mechanisms of Interorgan Crosstalk in Osteoarthritis | NIH | National Institute on Aging | 2024 | $1,476,001 | September 15, 2024 | August 31, 2027 | COLLINS, KELSEY HELEN-MARIE | reporter.nih.gov |
| Design and Validation of Easy-to-Adopt Mass Spectrometry Assays of Importance to Obesity | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $1,473,524 | September 20, 2019 | January 31, 2025 | VAN EYK, JENNIFER E | reporter.nih.gov |
| Deep Learning-based Imaging Biomarkers for Knee Osteoarthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2023 | $1,471,178 | July 2, 2019 | October 31, 2024 | DENIZ, CEM MURAT | reporter.nih.gov |
| Activation of endogenous progenitors via a nanoparticle-conjugated fibrous system to enhance meniscus repair | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 to 2025 | $1,467,367 | February 20, 2023 | November 30, 2027 | QIN, LING | reporter.nih.gov |
| Imaging and therapeutic targeting of tissue crosstalk in the injured knee | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 to 2025 | $1,454,755 | March 15, 2024 | February 28, 2029 | RUIZ GARZON, MARIA AMPARO | reporter.nih.gov |
| Synthetic Cartilage-Capped, Regenerative Osteochondral Plugs to Heal Osteochondral Defects | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 to 2025 | $1,449,070 | January 1, 2024 | December 31, 2025 | GRUNLAN, MELISSA | reporter.nih.gov |
| Signaling circuits that drive cell movement and ligand scavenging by chemokine receptor CCR2 | NIH | National Institute of General Medical Sciences | 2021 to 2023 | $1,448,376 | May 1, 2020 | January 31, 2025 | HANDEL, TRACY M | reporter.nih.gov |
| Profiling the human gut microbiome for potential analgesic bacterial therapies | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $1,446,416 | September 24, 2021 | May 31, 2023 | STRANDWITZ, PHILIP PETER | reporter.nih.gov |
| Cannabis Use Impact on Pain and Recovery Post-Surgery - The Role of the Endocannabinoid System | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $1,443,561 | September 5, 2025 | August 31, 2030 | INGRAM, SUSAN L | reporter.nih.gov |
| Integrative Predictors of Temporomandibular Degenerative Joint Disease | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2025 | $1,439,575 | September 10, 2013 | January 30, 2026 | CEVIDANES, LUCIA H | reporter.nih.gov |
| HSS Research Institute Rheumatology Training | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $1,438,910 | May 1, 2017 | April 30, 2027 | SALMON, JANE E | reporter.nih.gov |
| Early Detection and Monitoring of Osteonecrosis of the Femoral Head | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 to 2025 | $1,436,590 | March 1, 2023 | January 31, 2028 | JOHNSON, CASEY PETER | reporter.nih.gov |
| The Role of Sodium Channel Nav1.7 in Osteoarthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 to 2025 | $1,434,901 | March 18, 2024 | August 31, 2028 | LIU, CHUANJU | reporter.nih.gov |
| Interdisciplinary Training in Rheumatic Diseases | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $1,431,535 | May 1, 2010 | May 31, 2026 | MAJOR, AMY S | reporter.nih.gov |
| Complement in the Pathogenesis of Autoimmune Arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $1,418,939 | September 10, 2004 | November 30, 2025 | HOLERS, VERNON MICHAEL | reporter.nih.gov |
| Adding Bright Light Treatment to Cognitive-Behavioral Therapy for Insomnia to Prevent Chronic Post-Surgical Pain in Older Adults | NIH | National Institute on Aging | 2024 to 2025 | $1,415,293 | August 1, 2024 | July 31, 2029 | SMITH, MICHAEL T | reporter.nih.gov |
| Expanded fibroblast subset drives pathology in rheumatoid arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $1,413,588 | February 1, 2015 | August 31, 2026 | BRENNER, MICHAEL B. | reporter.nih.gov |
| Bridging the gap between GWAS and mechanism in arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $1,412,097 | December 1, 2018 | March 31, 2030 | NIGROVIC, PETER A | reporter.nih.gov |
| Molecular mechanisms of TAK1 regulation in rheumatoid arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2025 | $1,407,925 | August 12, 2025 | July 31, 2028 | AHMED, SALAH-UDDIN | reporter.nih.gov |
| Neuroimaging Measures of Psychosocial Stress as Predictors of Articular and Arterial Inflammation, Cardiometabolic Disease, and Treatment Response in Rheumatoid Arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2023 | $1,396,744 | September 27, 2021 | August 31, 2027 | BATHON, JOAN MARIE | reporter.nih.gov |
| Inflammation and Cardiovascular Disease in Rheumatoid Arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2022 | $1,381,165 | May 1, 2004 | May 31, 2024 | BATHON, JOAN MARIE | reporter.nih.gov |
| Role of T-bet B cells in rheumatoid arthritis | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,373,874 | December 12, 2023 | October 31, 2028 | ANOLIK, JENNIFER HOWITT | reporter.nih.gov |
| Borrelia burgdorferi mitogen in development of arthritis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $1,372,498 | April 1, 1993 | December 31, 2025 | WEIS, JANIS J. | reporter.nih.gov |
| Development of Sodium Fluoride PET-MRI for Quantitative Assessment of Knee Osteoarthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2023 | $1,369,656 | August 16, 2019 | June 30, 2025 | GOLD, GARRY E | reporter.nih.gov |
| Defining the unique capacity of the miniature joint model for investigating the role of adipose tissue and its impacts on osteoarthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 to 2025 | $1,365,070 | May 15, 2024 | April 30, 2029 | LIN, HANG | reporter.nih.gov |
| Metabolomic Profiling to Identify Candidate Biomarker Profiles and Molecular Endotypes for Osteoarthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 to 2025 | $1,362,647 | August 10, 2023 | July 31, 2028 | JUNE, RONALD KENT | reporter.nih.gov |
| Factor VIIa-released extracellular vesicles: Their role in hemostasis and beyond | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,357,616 | March 15, 2024 | February 29, 2028 | LELLA, VIJAYA MOHAN RAO | reporter.nih.gov |
| Interpretation and Utility of Novel Composite Structural Endpoints of Cumulative Damage and Disease Activity in Knee Osteoarthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2023 | $1,355,310 | June 1, 2021 | June 30, 2023 | DRIBAN, JEFFREY B | reporter.nih.gov |
| Targeting the PTH1R Signaling Pathway for Osteoarthritis Therapy by a Novel Disruptor Peptide | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2024 | $1,348,776 | August 1, 2020 | July 31, 2025 | WANG, BIN | reporter.nih.gov |
| Preclinical assessment of a novel systemic drug candidate for osteoarthritic pain | NIH | National Institute of Neurological Disorders and Stroke | 2023 | $1,348,453 | June 1, 2023 | May 31, 2025 | EVSEENKO, DENIS | reporter.nih.gov |
| Chondrocyte DNA Double-Strand Breaks in the Pathogenesis of Osteoarthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2024 | $1,331,484 | May 7, 2020 | April 30, 2025 | JONASON, JENNIFER HARRELL | reporter.nih.gov |
| Clinical Interpretation of PROMs in Care of Knee Osteoarthritis and TJR | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 to 2025 | $1,331,338 | July 16, 2024 | April 30, 2028 | FRANKLIN, PATRICIA D | reporter.nih.gov |
| Biomechanics of Cartilage: Roles of Decorin in ECM Assembly and Degradation | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2024 | $1,326,261 | August 1, 2019 | December 31, 2025 | HAN, LIN | reporter.nih.gov |
| Engineering Polymers to Scavenge DAMPs in Arthritis and Lupus | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2022 | $1,303,670 | August 15, 2018 | July 31, 2024 | SULLENGER, BRUCE ALAN | reporter.nih.gov |
| Characterizing the negative signaling in dendritic cells and macrophages to attenuate inflammation and bone destruction in rheumatoid arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2024 | $1,290,781 | February 15, 2020 | December 31, 2025 | LI, YI-PING | reporter.nih.gov |
| Cellular Senescence Network: New Imaging Tools for Arthritis Imaging | NIH | National Cancer Institute | 2023 to 2024 | $1,289,471 | September 23, 2021 | August 31, 2025 | DALDRUP-LINK, HEIKE ELIZABETH | reporter.nih.gov |
| Epigenetic Mechanisms That Drive Genetic Risk in Juvenile Arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2023 | $1,284,216 | September 26, 2022 | February 24, 2024 | JARVIS, JAMES N | reporter.nih.gov |
| Mechanism of Tgfbr2 in Chondroprotection | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2024 | $1,283,931 | April 1, 2013 | March 31, 2026 | SERRA, ROSA A. | reporter.nih.gov |
| Lipid Metabolism in Articular Cartilage and OA Pathogenesis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 to 2025 | $1,283,775 | June 12, 2024 | May 31, 2029 | SHEN, JIE | reporter.nih.gov |
| Novel injectable analgesic delivery system for musculoskeletal pain management | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2023 | $1,280,693 | August 1, 2019 | June 30, 2025 | NAIR, LAKSHMI S | reporter.nih.gov |
| Epigenetic Mechanisms That Drive Genetic Risk in Juvenile Arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 to 2025 | $1,278,332 | September 26, 2022 | August 31, 2027 | JARVIS, JAMES N | reporter.nih.gov |
| How Partial Meniscectomy Affects Contact Mechanics and Tissue Response | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2023 | $1,275,050 | August 12, 2019 | April 30, 2025 | MAHER, SUZANNE A. | reporter.nih.gov |
| The roles and mechanisms of inflammation resolution in the development of Rheumatoid Arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 to 2024 | $1,268,125 | September 1, 2023 | August 31, 2028 | NORRIS, JILL M | reporter.nih.gov |
| Beyond Heart Disease in Rheumatoid Arthritis: Multimorbidity | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2022 | $1,267,216 | September 1, 2000 | September 21, 2023 | CROWSON, CYNTHIA S | reporter.nih.gov |
| Molecular mechanisms governing chikungunya virus binding, tropism, and pathogenesis | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,262,565 | July 3, 2024 | May 31, 2029 | SILVA, LAURIE A. | reporter.nih.gov |
| Mechanotransduction in Meniscus Health and Repair | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2023 | $1,257,415 | January 15, 2019 | December 31, 2024 | MCNULTY, AMY L | reporter.nih.gov |
| Cbf mediates articular cartilage regeneration and repair in aging | NIH | National Institute on Aging | 2021 to 2023 | $1,250,727 | August 1, 2019 | April 30, 2026 | CHEN, WEI | reporter.nih.gov |
| Role of CCR2 in osteoarthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $1,245,594 | August 1, 2017 | May 31, 2029 | LONGOBARDI, LARA | reporter.nih.gov |
| Bioactive Injectable Cell Scaffold for Meniscus Injury Repair in a Large Animal Model | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 to 2025 | $1,244,807 | September 4, 2023 | August 31, 2028 | JAYASURIYA, CHATHURAKA TEEKSHANA | reporter.nih.gov |
| The Pregnancy Transcriptome in Rheumatoid Arthritis - Renewal | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $1,238,738 | September 20, 2017 | August 31, 2030 | JAWAHEER, DAMINI | reporter.nih.gov |
| Ly6 family members in neutrophil biology | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2024 | $1,228,273 | July 8, 2014 | June 30, 2026 | NIGROVIC, PETER A | reporter.nih.gov |
| Development of Kv1.3 Monoclonal Antibodies Targeting TEM Cells for Treating Autoimmune Disorders | NIH | National Institute of General Medical Sciences | 2021 to 2022 | $1,223,786 | September 5, 2014 | September 30, 2024 | RUCKER, JOSEPH BENJAMIN | reporter.nih.gov |
| Identifying Novel Biological Pathways for Gout using DNA Methylation and Genetics | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2023 | $1,218,051 | September 21, 2018 | November 30, 2023 | TIN, ADRIENNE | reporter.nih.gov |
| Brain Mechanisms of Chronic Low-Back Pain: Specificity and Effects of Aging and Sex | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $1,214,654 | April 1, 2023 | March 31, 2028 | GEHA, PAUL | reporter.nih.gov |
| WNT signaling in chondrocyte biology and osteoarthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 to 2025 | $1,208,493 | September 1, 2024 | August 31, 2029 | WU, CHIA-LUNG | reporter.nih.gov |
| GP130/STAT3 signalling in articular cartilage development and regeneration | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2022 | $1,208,109 | April 1, 2018 | January 31, 2024 | EVSEENKO, DENIS | reporter.nih.gov |
| Epigenetic Regulation in Cartilage Tissue | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 to 2025 | $1,207,511 | March 1, 2016 | March 31, 2029 | O'KEEFE, REGIS J | reporter.nih.gov |
| Robotic System for Spinal Decompression and Interbody Fusion | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2023 | $1,207,172 | April 18, 2022 | March 31, 2026 | ARMAND, MEHRAN | reporter.nih.gov |
| Determining the impact of stromal cell-mediated type I IFN signaling on alphavirus pathogenesis | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,206,704 | June 13, 2024 | April 30, 2029 | LENSCHOW, DEBORAH J | reporter.nih.gov |
| Uncovering the Genetic Mechanisms Behind Joint-Specific Osteoarthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2022 | $1,202,184 | April 1, 2018 | January 31, 2024 | CAPELLINI, TERENCE D | reporter.nih.gov |
| Unicondylar Resurfacing in an Ovine Osteoarthritis Disease Model | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2024 | $1,199,996 | September 8, 2015 | July 31, 2025 | ESTES, BRADLEY T | reporter.nih.gov |
| Regulation of inflammation by the ubiquitin proteasome pathway | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 to 2025 | $1,195,694 | February 1, 2024 | December 31, 2028 | BECK, DAVID | reporter.nih.gov |
| Roles of Type III Collagen in the Matrix Assembly and Mechanobiology of Cartilage | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 to 2025 | $1,194,196 | May 10, 2024 | April 30, 2029 | HAN, LIN | reporter.nih.gov |
| The adaptive response of skeletal muscle, bone, and cartilage to severe knee trauma involving ACL disruption with and without concomitant injury to the meniscus | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2023 | $1,193,778 | July 1, 2020 | June 30, 2025 | BEYNNON, BRUCE | reporter.nih.gov |
| Uncovering the role of Setbp1 in fibroblast-like synoviocytes during inflammatory arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $1,188,998 | September 6, 2017 | July 31, 2029 | BHATTARAM, PALLAVI | reporter.nih.gov |
| Modulating PTOA development with parathyroid hormone | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 to 2025 | $1,187,907 | September 15, 2023 | August 31, 2028 | VAN DER MEULEN, MARJOLEIN C | reporter.nih.gov |
| Systemic Inflammation in Microphysiological Models of Muscle and Vascular Disease | NIH | National Center for Advancing Translational Sciences | 2021 | $1,186,828 | August 1, 2017 | June 30, 2022 | TRUSKEY, GEORGE A | reporter.nih.gov |
| Individual cell bioprinting to generate multi-tissue type condensations for osteochondral tissue regeneration | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 to 2025 | $1,186,717 | April 5, 2023 | February 29, 2028 | ALSBERG, EBEN | reporter.nih.gov |
| Depositing Data Generated from Drug Test on microJoint Model into the Microphysiology Systems Database | NIH | National Center for Advancing Translational Sciences | 2021 | $1,186,687 | August 20, 2017 | June 30, 2023 | LIN, HANG | reporter.nih.gov |
| NEURAXIAL AAVS TARGETING DRG CHANNELS INVOLVED IN CHRONIC POST INFLAMMATORY PAIN | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $1,182,994 | January 1, 2024 | December 31, 2028 | YAKSH, TONY L. | reporter.nih.gov |
| Roles of the Src-Family Kinases LynA and LynB in Macrophage Inflammatory Signaling | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2022 | $1,175,786 | September 1, 2018 | August 31, 2025 | FREEDMAN, TANYA S. | reporter.nih.gov |
| Longitudinal Biomechanics and Patient-Reported Outcomes after Periacetabular Osteotomy for Developmental Dysplasia of the Hip | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 to 2024 | $1,172,323 | February 10, 2023 | December 31, 2025 | HARRIS, MICHAEL D | reporter.nih.gov |
| Targeting hexokinase-2 in rheumatoid arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2022 | $1,170,750 | August 15, 2018 | May 31, 2024 | GUMA, MONICA | reporter.nih.gov |
| Contribution of the NOD/RIPK2 signaling pathway to osteoarthritis susceptibility | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 to 2025 | $1,169,691 | April 1, 2024 | March 31, 2029 | JURYNEC, MICHAEL J | reporter.nih.gov |
| Microphysiological joint-on-chip platform for the study of arthritic diseases | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 to 2025 | $1,162,683 | August 15, 2024 | July 31, 2029 | NEU, COREY P | reporter.nih.gov |
| Mapping temporomandibular joint (TMJ) degeneration and pain | NIH | National Institute of Dental & Craniofacial Research | 2024 to 2025 | $1,161,054 | July 1, 2024 | April 30, 2029 | CHEN, JIANFU | reporter.nih.gov |
| Prevention of PTOA via regulation of the cytomechanics of chondrocytes | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $1,160,687 | September 1, 2020 | July 31, 2026 | LU, X. LUCAS | reporter.nih.gov |
| A Novel Glycosaminoglycan Mimetic Scaffold for Cartilage Repair | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $1,152,862 | March 16, 2021 | February 28, 2027 | ARINZEH, TREENA LYNNE | reporter.nih.gov |
| Roles of SOX8 and SOX9 in Adult Articular Cartilage | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2022 | $1,149,371 | July 8, 2018 | June 30, 2024 | LEFEBVRE, VERONIQUE M | reporter.nih.gov |
| Mitochondrial Malfunction in T Cell Aging and Tissue Inflammation | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,144,649 | March 1, 2024 | February 28, 2029 | WEYAND, CORNELIA M. | reporter.nih.gov |
| Disc-Facet Crosstalk During Spinal Degeneration and Repair | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 to 2025 | $1,143,510 | September 26, 2024 | August 31, 2029 | GULLBRAND, SARAH E | reporter.nih.gov |
| Deciphering Pathways Driving Inflammatory Fibroblast Effector Functions in RA | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2023 | $1,136,015 | August 1, 2019 | July 31, 2024 | BRENNER, MICHAEL B. | reporter.nih.gov |
| Sex Dimorphism in Age-Related Knee Osteoarthritis | NIH | National Institute on Aging | 2024 to 2025 | $1,132,326 | September 15, 2024 | May 31, 2028 | AMBROSIO, FABRISIA | reporter.nih.gov |
| OA Pathogenesis beyond Cartilage: A preclinical study of the sources of OA pain | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2022 | $1,130,706 | March 1, 2018 | February 29, 2024 | ALLEN, KYLE D | reporter.nih.gov |
| Pathogenesis of autoimmune valvular carditis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,129,857 | July 15, 2014 | September 30, 2024 | BINSTADT, BRYCE | reporter.nih.gov |
| The role of vascular failure and biomechanical stress in the development, progression and healing of osteochondritis dissecans lesions | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 to 2025 | $1,129,716 | August 9, 2024 | May 31, 2029 | TOTH, FERENC | reporter.nih.gov |
| Multidisciplinary Rheumatology Training Program | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $1,127,955 | July 1, 2003 | June 30, 2029 | BINGHAM, CLIFTON O | reporter.nih.gov |
| Objective tests utilizing Vibrational Spectroscopy for Diagnosis and Severity of Fibromyalgia and Related Pain Syndromes | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $1,127,024 | September 15, 2020 | March 31, 2027 | HACKSHAW, KEVIN VICTOR | reporter.nih.gov |
| Carrier Free siRNA Conjugates as Disease Modifying Osteoarthritis Drugs | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 to 2025 | $1,122,583 | September 10, 2024 | July 31, 2029 | DUVALL, CRAIG LEWIS | reporter.nih.gov |
| Negative Regulation of Osteoclastogenesis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 to 2025 | $1,122,005 | August 1, 2024 | July 31, 2029 | IVASHKIV, LIONEL B | reporter.nih.gov |
| Understanding the structural dynamics of TNF receptors | NIH | National Institute of General Medical Sciences | 2021 to 2023 | $1,120,569 | June 1, 2019 | May 31, 2024 | SACHS, JONATHAN N | reporter.nih.gov |
| Microbiota Control Lung Th17 Cell Response and Plasticity Leading to Autoimmune Lung Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,115,457 | August 1, 2020 | July 31, 2025 | WU, HSIN-JUNG JOYCE | reporter.nih.gov |
| Disease Modifying Analgesia with CA8 Gene Therapy | NIH | National Institute of Neurological Disorders and Stroke | 2023 | $1,109,446 | September 16, 2023 | September 30, 2026 | LEVITT, ROY C. | reporter.nih.gov |
| Magnesium and Arthritis Pathogenesis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2023 | $1,103,784 | January 15, 2019 | December 31, 2023 | GULKO, PERCIO S | reporter.nih.gov |
| Bacterial peptidylarginine deiminase, a link between gums and joint disease | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2023 | $1,093,593 | February 1, 2013 | March 31, 2025 | POTEMPA, JAN S | reporter.nih.gov |
| Mechanism-rooted therapeutic strategies for immune-related toxicities induced by checkpoint inhibitors | NIH | National Cancer Institute | 2023 to 2025 | $1,093,197 | July 1, 2023 | June 30, 2028 | NURIEVA, ROZA INSAFETDINOVNA | reporter.nih.gov |
| Treatment of Meniscal Problems in Osteoarthritis: TeMPO | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2022 | $1,093,180 | April 15, 2017 | March 31, 2023 | KATZ, JEFFREY NEIL | reporter.nih.gov |
| Comparing the Impact of Voluntary and Mandatory Bundled Payments on Disparities in Surgical Care | NIH | National Institute on Minority Health and Health Disparities | 2021 to 2022 | $1,089,541 | June 19, 2019 | January 31, 2024 | NAVATHE, AMOL S | reporter.nih.gov |
| Characterizing and Restoring Joint Motion in Patients with Hallux Rigidus | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2024 | $1,089,490 | September 1, 2020 | August 31, 2025 | LEDOUX, WILLIAM R. | reporter.nih.gov |
| Genetics of Osteoarthritis Susceptibility, Heterogeneity and Progression | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 to 2025 | $1,087,578 | August 22, 2024 | July 31, 2029 | MCDONALD DONNELLY, MERRY-LYNN NOELLE | reporter.nih.gov |
| Repurposing FDA-approved drugs for the treatment of osteoarthritis using high-throughput screening in microphysiological models | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 to 2025 | $1,085,742 | August 15, 2024 | July 31, 2029 | LIN, HANG | reporter.nih.gov |
| Regulation of cytosolic pattern recognition receptor signaling in macrophages | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $1,085,226 | March 11, 2013 | March 1, 2024 | STEHLIK, CHRISTIAN | reporter.nih.gov |
| Environmental Factors Associated with the Development of Osteoarthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 to 2025 | $1,081,730 | February 1, 2024 | January 31, 2027 | DRIBAN, JEFFREY B | reporter.nih.gov |
| The natural release of unusual peptidoglycan fragments drives persistent Lyme disease symptoms in susceptible hosts | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,073,058 | June 15, 2023 | May 31, 2028 | JUTRAS, BRANDON LYON | reporter.nih.gov |
| The Role of MicroRNA in Osteoarthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2022 | $1,069,484 | August 1, 2017 | October 31, 2024 | HUANG, JIAN | reporter.nih.gov |
| Cellular Senescence Network: New Imaging Tools for Arthritis Imaging | NIH | National Cancer Institute | 2021 to 2022 | $1,059,697 | September 23, 2021 | August 31, 2023 | DALDRUP-LINK, HEIKE ELIZABETH | reporter.nih.gov |
| Sleep, Pain, Active Social Life, and Inflammation (SPAI) | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,056,093 | February 20, 2023 | January 31, 2027 | LEE, SOOMI | reporter.nih.gov |
| INPP5E Signaling and Treatment in Rheumatoid Arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 to 2025 | $1,055,452 | July 18, 2024 | June 30, 2029 | YANG, SHUYING | reporter.nih.gov |
| Defining the host and pathogen determinants of peptidoglycan induced pathophysiology in Lyme disease | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,053,949 | August 1, 2024 | July 31, 2027 | JUTRAS, BRANDON LYON | reporter.nih.gov |
| Role of PTPN2 in rheumatoid arthritis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $1,052,726 | June 1, 2019 | April 9, 2023 | BOTTINI, NUNZIO | reporter.nih.gov |
| The immunological mechanism of PGRNs anti-inflammatory effect - Renewal - 1 | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2022 | $1,052,436 | September 1, 2012 | June 30, 2024 | LIU, CHUANJU | reporter.nih.gov |
| Device Automation of an FDA-cleared CD-Microfluidic Platform for Rapid Tissue Microsizing | NIH | National Center for Advancing Translational Sciences | 2025 | $1,050,276 | September 25, 2025 | August 31, 2027 | ZOBI, AHMED NABIL | reporter.nih.gov |
| Weight loss, in vivo cartilage mechanics, and joint health | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2023 | $1,048,432 | January 15, 2019 | December 31, 2025 | DEFRATE, LOUIS E. | reporter.nih.gov |
| 15-LOX-1 as a druggable target in the acute to chronic pain transition of rheumatoid arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2023 | $1,041,920 | July 1, 2019 | May 31, 2025 | GREGUS, ANN MARIE | reporter.nih.gov |
| Control of B cell differentiation by IFNg induced transcription factors | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $1,039,868 | February 14, 2014 | November 30, 2025 | LUND, FRANCES E. | reporter.nih.gov |
| CD8 T cell derived Granzyme K activates complement that drives synovial fibroblast inflammation | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 to 2025 | $1,028,392 | September 22, 2023 | August 31, 2028 | BRENNER, MICHAEL B. | reporter.nih.gov |
| Viscoelastic Properties of Normal and OA Chondrons | NIH | National Institute on Aging | 2021 to 2022 | $1,027,495 | January 1, 1998 | March 31, 2025 | GUILAK, FARSHID | reporter.nih.gov |
| Novel Non-Contrast MRI to Assess Synovitis in Osteoarthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 to 2025 | $1,017,844 | April 19, 2024 | February 28, 2029 | KOGAN, FELIKS | reporter.nih.gov |
| Title: BMP/TGFbeta crosstalk in cartilage maintenance and osteoarthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2023 | $1,015,872 | July 19, 2018 | April 30, 2024 | LYONS, KAREN M. | reporter.nih.gov |
| Dissecting molecular mechanisms implicated in age- and osteoarthritis-related decline in anabolism in articular cartilage | NIH | National Institute on Aging | 2021 to 2023 | $1,014,750 | February 1, 2019 | November 30, 2024 | EVSEENKO, DENIS | reporter.nih.gov |
| Efficacy of MeniscoFix for Sub-Total Meniscal Replacement: A Comprehensive Approach in Cadaver Knees and an Ovine Surgical Model | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2025 | $1,013,912 | July 15, 2022 | June 30, 2027 | WEADOCK, KEVIN S | reporter.nih.gov |
| Newly Identified T Peripheral Helper (Tph) Cells in Rheumatoid Arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2022 | $1,010,963 | September 13, 2018 | June 30, 2023 | BRENNER, MICHAEL B. | reporter.nih.gov |
| Therapeutic targeting of GPCR Gbetagamma-GRK2 in osteoarthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2023 | $998,289 | February 21, 2019 | December 31, 2024 | KAMAL, FADIA ALI | reporter.nih.gov |
| Piezo1 and Piezo2-dependent cartilage health and disease | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 to 2025 | $996,072 | April 1, 2023 | March 31, 2028 | LEE, WHASIL | reporter.nih.gov |
| Understanding Interleukin-18 Mediated Susceptibility to Systemic Hyperinflammation | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2023 | $993,999 | April 1, 2021 | March 31, 2025 | CANNA, SCOTT WILLIAM | reporter.nih.gov |
| T peripheral regulatory cells as modulators of T cell-B cell interactions in arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 to 2025 | $991,974 | December 15, 2023 | November 30, 2028 | HENDERSON, LAUREN A | reporter.nih.gov |
| Training Program in Rheumatic and Musculoskeletal Diseases Research | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 to 2025 | $986,224 | May 1, 2016 | April 30, 2028 | MOUNTZ, JOHN D | reporter.nih.gov |
| Tfh cells: linking the gut microbiota to a gut-distal autoimmune disease | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $985,398 | August 1, 2013 | January 31, 2025 | WU, HSIN-JUNG JOYCE | reporter.nih.gov |
| Local immunometabolism modulating biomaterials for immunosuppressive applications | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2023 | $978,635 | May 14, 2021 | August 15, 2023 | ACHARYA, ABHINAV | reporter.nih.gov |
| Pain-related Brain Mechanisms for Pain Catastrophizing Behavior in Response to Home-based Mindfulness-based Meditation Paired with Transcranial Direct Current Stimulation | NIH | National Institute of Nursing Research | 2022 | $973,809 | September 1, 2022 | January 31, 2025 | AHN, HYOCHOL | reporter.nih.gov |
| Obesity, Biomechanics, and Inflammation in Osteoarthritis | NIH | National Institute on Aging | 2021 to 2023 | $968,625 | September 30, 2013 | April 30, 2025 | GUILAK, FARSHID | reporter.nih.gov |
| Advancing Quality and Outcomes Measurement in Rheumatology | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $965,394 | February 15, 2019 | November 30, 2028 | YAZDANY, JINOOS | reporter.nih.gov |
| Gene Regulation as a Foundation for Autoimmune Disease Prevention | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $963,738 | June 1, 2017 | May 31, 2023 | WEIRAUCH, MATTHEW TYSON | reporter.nih.gov |
| Combination Therapy of Home-based Trans-cranial Direct Current Stimulation and Mindfulness-based Meditation for Self-management of Clinical Pain and Symptoms in Older Adults with Knee Osteoarthritis | NIH | National Institute of Nursing Research | 2023 to 2025 | $963,281 | April 14, 2020 | November 30, 2025 | AHN, HYOCHOL | reporter.nih.gov |
| Targeted vaccines against pulmonary NTM infections in vulnerable populations | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $950,092 | December 20, 2024 | November 30, 2029 | COLER, RHEA N | reporter.nih.gov |
| Obesity-Induced Inflammatory Mediators Predict Lack of Response in Patients with Rheumatoid Arthritis Starting Biological Therapies | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 to 2025 | $946,648 | September 1, 2024 | August 31, 2029 | GUMA, MONICA | reporter.nih.gov |
| Defining the Role of Thymic Tolerance in the Pathogenesis of the COPA syndrome | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $946,280 | January 16, 2018 | December 31, 2023 | SHUM, ANTHONY | reporter.nih.gov |
| Large-scale automatic analysis of the OAI magnetic resonance image dataset | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2022 | $929,619 | August 15, 2017 | April 30, 2024 | NIETHAMMER, MARC | reporter.nih.gov |
| Molecular Engineering of Cartilage PCM Mechanotransduction in Osteoarthritis Using Biomimetic Proteoglycans | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2024 | $927,833 | July 10, 2022 | June 30, 2027 | MARCOLONGO, MICHELE S | reporter.nih.gov |
| Cincinnati Training Program in Pediatric Rheumatology | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $920,093 | May 1, 2016 | April 30, 2030 | GROM, ALEXEI A | reporter.nih.gov |
| DNA Repair and Mitochondrial Dysfunction in T Cell Aging | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2024 | $919,378 | December 20, 2013 | December 31, 2025 | WEYAND, CORNELIA M. | reporter.nih.gov |
| Remote Tai Chi for Knee Osteoarthritis: an Embedded Pragmatic Trial | NIH | National Center for Complementary & Integrative Health | 2023 | $911,699 | May 19, 2023 | August 31, 2024 | WANG, CHENCHEN | reporter.nih.gov |
| KLF4 in joint degradation and regeneration | NIH | National Institute on Aging | 2021 to 2022 | $907,736 | September 30, 2018 | May 31, 2025 | LOTZ, MARTIN K | reporter.nih.gov |
| Restriction of psoriatic skin and joint disease by A20 | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $907,333 | February 5, 2021 | November 30, 2025 | RAZANI, BAHRAM | reporter.nih.gov |
| Therapeutic role of NFAT1 Transcription Factor in Osteoarthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 to 2025 | $900,405 | August 1, 2024 | July 31, 2029 | WANG, JINXI | reporter.nih.gov |
| Boston University Rheumatology Research Training (BURRT) T32 Program | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $894,646 | June 1, 2022 | May 31, 2027 | NEOGI, TUHINA | reporter.nih.gov |
| Quantitative UTE MR Imaging: Sensitive Biomarkers for Osteoarthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2022 | $887,284 | September 1, 2013 | February 29, 2024 | DU, JIANG | reporter.nih.gov |
| Engineering synthetic ligands with potent allosteric inhibition of tumornecrosis factor receptors | NIH | National Institute of Biomedical Imaging and Bioengineering | 2021 to 2022 | $878,581 | September 15, 2019 | June 30, 2024 | HACKEL, BENJAMIN | reporter.nih.gov |
| A simple and quantitative clinical assessment of neuromuscular recovery after ACL injury | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2022 | $868,386 | September 12, 2019 | August 30, 2025 | VALERO, ERIKA | reporter.nih.gov |
| Prognostic Study of the Risk Factors for Contralateral ACL Injury | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2022 | $861,401 | September 7, 2007 | August 31, 2025 | BEYNNON, BRUCE | reporter.nih.gov |
| T resident memory cells in arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2023 | $851,419 | July 1, 2019 | May 31, 2025 | NIGROVIC, PETER A | reporter.nih.gov |
| A Treatment Paradigm for Femoracetabular Impingement (FAI) | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 | $849,426 | June 1, 2020 | May 31, 2023 | ESTES, BRADLEY T | reporter.nih.gov |
| Tissue Engineering Approaches for Improved Treatment of Early Stage Osteonecrosis of the Hip | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2022 | $844,366 | July 5, 2018 | April 30, 2024 | YANG, YUNZHI | reporter.nih.gov |
| Human antibodies as broad alphavirus immunotherapeutics | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $843,620 | June 6, 2025 | May 31, 2030 | LAI, JONATHAN R. | reporter.nih.gov |
| The Exposome in Rheumatoid Arthritis and Systemic Lupus Erythematosus: EXACT Network Planning | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 to 2025 | $843,158 | August 18, 2025 | August 31, 2026 | NORRIS, JILL M | reporter.nih.gov |
| Systemic contribution of age-associated epigenetic mechanisms to osteoarthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2022 | $842,622 | September 9, 2019 | June 30, 2025 | YAU, MICHELLE SZU-HUEI | reporter.nih.gov |
| Precision Monitoring of Treatment Response in Early Psoriatic Arthritis: Integrating at-Home RNA Microsampling into Ongoing, Remote, Smart Phone-Based, Digital Data Capturing | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 to 2025 | $838,694 | June 15, 2024 | May 31, 2028 | SCHER, JOSE U. | reporter.nih.gov |
| Negative Regulation of Osteoclastogenesis | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2022 | $831,820 | September 8, 2008 | March 31, 2024 | IVASHKIV, LIONEL B | reporter.nih.gov |
| Mechanisms of Oxytocins Analgesia in Older Adults | NIH | National Institute on Aging | 2021 to 2022 | $828,868 | August 1, 2018 | April 30, 2024 | CRUZ-ALMEIDA, YENISEL | reporter.nih.gov |
| Ultrashort Echo Time Magnetic Resonance Imaging of Hemophilic Arthropathy | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 to 2025 | $827,934 | June 1, 2024 | February 28, 2027 | JANG, HYUNGSEOK | reporter.nih.gov |
| ACL Deficiency Modifies Topographical Degradation in Posttraumatic Osteoarthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2022 | $824,998 | April 1, 2016 | March 31, 2025 | XIA, YANG | reporter.nih.gov |
| Long-term Outcomes of Knee OA in the OAI Cohort | NIH | National Institute on Aging | 2021 | $819,214 | September 15, 2017 | May 31, 2024 | NEVITT, MICHAEL C | reporter.nih.gov |
| MicroRNA-based therapy for rheumatoid arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2022 | $817,760 | July 12, 2018 | June 30, 2024 | AHMED, SALAH-UDDIN | reporter.nih.gov |
| Osteogenic Regulation of Vascular Calcification | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $810,000 | September 30, 2001 | November 30, 2024 | TOWLER, DWIGHT A. | reporter.nih.gov |
| Regulation of Ubiquitination and Arthritis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $807,500 | May 5, 2018 | April 30, 2024 | MA, AVERIL I | reporter.nih.gov |
| Heart-Related Multiple Chronic Conditions in Primary Care: Behavioral Technology | NIH | National Heart, Lung, and Blood Institute | 2021 | $799,451 | April 1, 2017 | March 31, 2023 | GUSTAFSON, DAVID H | reporter.nih.gov |
| Treatment and prevention of osteoarthritis with an intra-articular disease-modifying regenerative therapy | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 to 2025 | $797,793 | August 5, 2024 | July 31, 2026 | ANGLE, SIDDHESH | reporter.nih.gov |
| Determining role of 14-3-3zeta in IL-17A signaling | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $795,696 | June 10, 2024 | April 30, 2030 | CHAKRAVARTI, RITU | reporter.nih.gov |
| Remote Exposome Monitoring for Autoimmune Diseases | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 to 2025 | $795,574 | September 18, 2023 | August 31, 2026 | LIAO, WILSON | reporter.nih.gov |
| A Pilot Randomized Controlled Trial of Resilience Coaching for Adolescents with Chronic Musculoskeletal Pain | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $794,396 | August 1, 2022 | June 30, 2027 | GMUCA, SABRINA ANDREA | reporter.nih.gov |
| Type I interferon Impacts Treatment Response in Rheumatoid Arthritis | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $790,560 | July 1, 2022 | June 30, 2027 | WAMPLER MUSKARDIN, THERESA | reporter.nih.gov |
| Determining role of 14-3-3zeta in IL-17A signaling | NIH | National Institute of Allergy and Infectious Diseases | 2024 | $790,019 | June 10, 2024 | February 13, 2025 | CHAKRAVARTI, RITU | reporter.nih.gov |
| Engineered cells as agents of arthritis therapy governed by artificial signaling | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 to 2025 | $788,242 | September 17, 2024 | July 31, 2029 | BRUNGER, JONATHAN MATTHEW | reporter.nih.gov |
| Alphavirus Pathogenesis and Immunity | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $782,871 | April 2, 2025 | March 31, 2030 | MORRISON, THOMAS E | reporter.nih.gov |
| A Randomized, Double-Blind, Controlled, Multi-Center Trial of Colchicine in Calcium Pyrophosphate Deposition Disease | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2025 | $777,869 | August 10, 2025 | July 31, 2030 | TEDESCHI, SARA K. | reporter.nih.gov |
| Development and preliminary testing of a peer narrative video intervention for older adults with chronic pain | NIH | National Institute on Aging | 2025 | $777,114 | September 24, 2024 | August 31, 2027 | UEBELACKER, LISA A | reporter.nih.gov |
| Temporal associations between systemic inflammation, cardiovascular risk profile and development of Alzheimer’s disease and related dementias in patients with rheumatoid arthritis | NIH | National Institute on Aging | 2022 to 2025 | $760,568 | August 1, 2022 | April 30, 2027 | MYASOEDOVA, ELENA | reporter.nih.gov |
| Risk Factors for End-Stage Glenohumeral Osteoarthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 to 2025 | $759,943 | September 18, 2024 | June 30, 2029 | ROWLANDS, ELIZABETH YANIK | reporter.nih.gov |
| A novel regulating pathway in osteoclastogenesis and arthritic bone resorption | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2022 | $756,427 | April 1, 2018 | January 31, 2024 | PARK-MIN, KYUNG-HYUN | reporter.nih.gov |
| Localization of Antibody Drugs to Arthritic Joints via Collagen Hybridization | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 to 2025 | $756,245 | August 22, 2024 | July 31, 2029 | YU, MICHAEL S | reporter.nih.gov |
| Mentoring Biomechanics Research in Osteoarthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $755,810 | April 1, 2018 | June 30, 2029 | SOUZA, RICHARD BRIAN | reporter.nih.gov |
| Biomechanics Contributions to Symptoms and Joint Health in Individuals with Rotator Cuff Tears | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 to 2025 | $753,068 | June 20, 2024 | April 30, 2028 | NICHOLS, JENNIFER A. | reporter.nih.gov |
| Host-Microbiota Interactions in Crohn's Disease-associated Spondyloarthritis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $751,598 | April 2, 2018 | January 31, 2023 | LONGMAN, RANDY S | reporter.nih.gov |
| Defining stress REsilience And Mindfulness Effects in Rheumatoid Arthritis (DREAMER) | NIH | National Center for Complementary & Integrative Health | 2022 to 2025 | $750,600 | January 1, 2022 | December 31, 2026 | PATTERSON, SARAH LYNN | reporter.nih.gov |
| Integrating brain and behavioral measures of central pain inhibition to personalize treatment in chronic pain management | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $748,927 | April 1, 2022 | February 28, 2027 | ALTER, BENEDICT J | reporter.nih.gov |
| The role of FGFR3 in the effects of PTH in the Mandibular Condyle | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2024 | $747,360 | April 1, 2020 | March 31, 2026 | DUTRA, ELIANE | reporter.nih.gov |
| Development of Drug Delivery Technology for Stem Cell Based TMJ Regeneration | NIH | National Institute of Dental & Craniofacial Research | 2021 | $742,838 | August 1, 2018 | January 31, 2024 | CHEN, MO | reporter.nih.gov |
| Elucidating the neuroimmune mechanisms underlying pain and inflammation in autoimmune arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2025 | $742,426 | September 20, 2023 | June 30, 2028 | JAIN, AAKANKSHA | reporter.nih.gov |
| Multidisciplinary Training in Molecular and Translational Rheumatology Research | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $741,678 | July 1, 2021 | June 30, 2026 | BATHON, JOAN MARIE | reporter.nih.gov |
| Understanding the Role of Somatic Mutations in Adult Inflammatory Diseases | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2024 | $739,530 | January 1, 2022 | December 31, 2025 | BECK, DAVID | reporter.nih.gov |
| TMJ-on-a-chip for delineating multi-tissue crosstalk in inflammation and pathophysiological mechanical loadings | NIH | National Institute of Dental & Craniofacial Research | 2025 | $738,929 | August 1, 2025 | April 30, 2030 | LEE, CHANG HUN | reporter.nih.gov |
| Using redox balance to guide surgical and therapeutic decisions for cartilage disease | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 to 2025 | $736,331 | September 1, 2024 | August 31, 2028 | HENAK, CORINNE R | reporter.nih.gov |
| Immune cell contributions to inflammatory arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2025 | $735,460 | April 10, 2025 | March 31, 2030 | WARD, NICOLE LEANNE | reporter.nih.gov |
| T cell expression of inflammatory chemokine receptors | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2025 | $735,372 | May 15, 2025 | February 28, 2030 | RAO, DEEPAK ANGARA | reporter.nih.gov |
| Association of the redesigned Comprehensive Care for Joint Replacement model with racial/ethnic and socioeconomic disparities in joint replacement surgeries | NIH | National Institute on Minority Health and Health Disparities | 2023 to 2024 | $734,538 | July 13, 2023 | January 31, 2027 | THIRUKUMARAN, CAROLINE PINTO | reporter.nih.gov |
| Green Light Therapy and Brain Mechanisms of Pain and Anxiety | NIH | National Center for Complementary & Integrative Health | 2025 | $733,870 | September 12, 2025 | May 31, 2030 | DA SILVA, JOYCE TEIXEIRA | reporter.nih.gov |
| Resolving the interaction network of cell surface receptors | NIH | National Institute of General Medical Sciences | 2024 to 2025 | $733,091 | September 1, 2024 | August 31, 2029 | SMITH, ADAM W. | reporter.nih.gov |
| Simulation framework to develop ankle exoskeleton gait assistance for older adults | NIH | National Institute on Aging | 2022 to 2024 | $727,327 | April 1, 2020 | March 31, 2026 | SONG, SEUNGMOON | reporter.nih.gov |
| Mentoring in Patient Oriented Research in Osteoarthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $718,915 | August 25, 2022 | July 31, 2027 | NELSON, AMANDA E | reporter.nih.gov |
| Integrated Cartilage Repair | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2022 | $716,032 | September 13, 2018 | June 30, 2025 | LU, HELEN H | reporter.nih.gov |
| The Role of Fat in Osteoarthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 to 2025 | $714,633 | August 1, 2023 | June 30, 2026 | COLLINS, KELSEY HELEN-MARIE | reporter.nih.gov |
| Multivalent Nano-conjugates for Targeted Penetration of and Delivery to Dense Extracellular Matrices | NIH | National Institute of Biomedical Imaging and Bioengineering | 2021 | $710,686 | September 15, 2018 | May 31, 2023 | HAMMOND, PAULA T | reporter.nih.gov |
Organizations
| Organization | Place | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|---|
| Brigham and Women's Hospital | Boston, MA | 53 | $56.1 million | 0 | $0 |
| Washington University | Saint Louis, MO | 40 | $43.8 million | 0 | $0 |
| Massachusetts General Hospital | Boston, MA | 22 | $42.3 million | 0 | $0 |
| University of California, San Francisco | San Francisco, CA | 34 | $42.2 million | 0 | $0 |
| Johns Hopkins University | Baltimore, MD | 24 | $37.8 million | 0 | $0 |
| University of Colorado Denver | Aurora, CO | 29 | $34.9 million | 0 | $0 |
| University of Florida | Gainesville, FL | 26 | $34.3 million | 0 | $0 |
| New York University School of Medicine | New York, NY | 24 | $28.3 million | 0 | $0 |
| University of Pittsburgh at Pittsburgh | Pittsburgh, PA | 20 | $27.6 million | 0 | $0 |
| University of Michigan at Ann Arbor | Ann Arbor, MI | 28 | $26.8 million | 0 | $0 |
| University of Pennsylvania | Philadelphia, PA | 26 | $26.5 million | 0 | $0 |
| Stanford University | Stanford, CA | 22 | $25.7 million | 0 | $0 |
| Oklahoma Medical Research Foundation | Oklahoma City, OK | 7 | $24.7 million | 0 | $0 |
| University of California, San Diego | La Jolla, CA | 28 | $24.4 million | 0 | $0 |
| Northwestern University at Chicago | Chicago, IL | 17 | $24.3 million | 0 | $0 |
| Rush University Medical Center | Chicago, IL | 9 | $22.7 million | 0 | $0 |
| Hospital for Special Surgery | New York, NY | 16 | $22 million | 0 | $0 |
| Univ of North Carolina Chapel Hill | Chapel Hill, NC | 32 | $21.5 million | 0 | $0 |
| University of Rochester | Rochester, NY | 14 | $21.2 million | 0 | $0 |
| Duke University | Durham, NC | 22 | $21 million | 0 | $0 |
| University of Alabama at Birmingham | Birmingham, AL | 13 | $15.7 million | 0 | $0 |
| Mayo Clinic Rochester | Rochester, MN | 17 | $15.6 million | 0 | $0 |
| University of Utah | Salt Lake City, UT | 14 | $14.2 million | 0 | $0 |
| Baylor College of Medicine | Houston, TX | 5 | $13.6 million | 0 | $0 |
| University of California at Davis | Davis, CA | 9 | $12.9 million | 0 | $0 |
| Columbia University Health Sciences | New York, NY | 13 | $12.8 million | 0 | $0 |
| Cleveland Clinic Lerner Com-Cwru | Cleveland, OH | 11 | $12.8 million | 0 | $0 |
| Brown University | Providence, RI | 2 | $12.6 million | 0 | $0 |
| Zetroz Systems, LLC | Trumbull, CT | 3 | $12.2 million | 0 | $0 |
| Vanderbilt University Medical Center | Nashville, TN | 10 | $12.1 million | 0 | $0 |
| University of Minnesota | Minneapolis, MN | 17 | $12 million | 0 | $0 |
| Univ of Arkansas for Med Scis | Little Rock, AR | 1 | $11.7 million | 0 | $0 |
| Wake Forest University | Winston Salem, NC | 4 | $10.9 million | 0 | $0 |
| Univ of Massachusetts Med SCH Worcester | Worcester, MA | 6 | $10.8 million | 0 | $0 |
| Tufts University Boston | Boston, MA | 6 | $10.4 million | 0 | $0 |
| Rhode Island Hospital | Providence, RI | 10 | $10.2 million | 0 | $0 |
| Cincinnati Childrens Hosp Med CTR | Cincinnati, OH | 10 | $9.5 million | 0 | $0 |
| University of Washington | Seattle, WA | 12 | $9.3 million | 0 | $0 |
| Children's Hosp of Philadelphia | Philadelphia, PA | 13 | $9.3 million | 0 | $0 |
| Tufts Medical Center | Boston, MA | 6 | $9.2 million | 0 | $0 |
| Benaroya Research Inst at Virginia Mason | Seattle, WA | 5 | $9.1 million | 0 | $0 |
| Scripps Research Institute, the | La Jolla, CA | 6 | $9 million | 0 | $0 |
| Kai Research, INC | Rockville, MD | 2 | $8.3 million | 0 | $0 |
| Boston Children's Hospital | Boston, MA | 14 | $8.1 million | 0 | $0 |
| University of Southern California | Los Angeles, CA | 10 | $7.9 million | 0 | $0 |
| University of Arizona | Tucson, AZ | 6 | $7.5 million | 0 | $0 |
| Cedars-Sinai Medical Center | Los Angeles, CA | 7 | $7.5 million | 0 | $0 |
| University of Illinois at Chicago | Chicago, IL | 6 | $7.4 million | 0 | $0 |
| Beth Israel Deaconess Medical Center | Boston, MA | 4 | $7.3 million | 0 | $0 |
| Icahn School of Medicine at Mount Sinai | New York, NY | 4 | $7.2 million | 0 | $0 |
| Trustees of Boston University | Boston, MA | 8 | $7 million | 0 | $0 |
| University of Colorado at Boulder | Boulder, CO | 4 | $6.6 million | 0 | $0 |
| Vanderbilt University | Nashville, TN | 7 | $6.5 million | 0 | $0 |
| Sloan-Kettering Inst Can Research | New York, NY | 1 | $6.3 million | 0 | $0 |
| Feinstein Institute for Medical Research | Manhasset, NY | 4 | $6.2 million | 0 | $0 |
| Yale University | New Haven, CT | 6 | $6.1 million | 0 | $0 |
| Harvard Medical School | Boston, MA | 5 | $5.4 million | 0 | $0 |
| Rise Therapeutics, LLC | Rockville, MD | 2 | $5.4 million | 0 | $0 |
| George Washington University | Washington, DC | 2 | $5.3 million | 0 | $0 |
| North Carolina State University | Raleigh, NC | 2 | $5.3 million | 0 | $0 |
| SUNY at Buffalo | Amherst, NY | 5 | $5.1 million | 0 | $0 |
| University of TX MD Anderson Can CTR | Houston, TX | 4 | $4.7 million | 0 | $0 |
| University of Delaware | Newark, DE | 7 | $4.7 million | 0 | $0 |
| George Mason University | Fairfax, VA | 1 | $4.6 million | 0 | $0 |
| Steadman Philippon Research Institute | Vail, CO | 3 | $4.6 million | 0 | $0 |
| University of Connecticut SCH of Med/dnt | Farmington, CT | 8 | $4.6 million | 0 | $0 |
| University of Montana | Missoula, MT | 1 | $4.6 million | 0 | $0 |
| Emory University | Atlanta, GA | 6 | $4.3 million | 0 | $0 |
| Cytex Therapeutics Inc. | Durham, NC | 4 | $4.2 million | 0 | $0 |
| Dorian Therapeutics, Inc. | San Carlos, CA | 1 | $4.2 million | 0 | $0 |
| Thomas Jefferson University | Philadelphia, PA | 4 | $4.1 million | 0 | $0 |
| Wake Forest University Health Sciences | Winston-Salem, NC | 3 | $4.1 million | 0 | $0 |
| Helixbind, Inc. | Boxborough, MA | 2 | $4 million | 0 | $0 |
| University of Connecticut | Storrs, CT | 5 | $3.7 million | 0 | $0 |
| Indiana University Indianapolis | Indianapolis, IN | 4 | $3.5 million | 0 | $0 |
| Northeastern University | Boston, MA | 5 | $3.4 million | 0 | $0 |
| University of Miami School of Medicine | Coral Gables, FL | 4 | $3.4 million | 0 | $0 |
| Van Andel Research Institute | Grand Rapids, MI | 2 | $3.3 million | 0 | $0 |
| Dartmouth College | Hanover, NH | 1 | $3.2 million | 0 | $0 |
| University of Maryland Baltimore | Baltimore, MD | 3 | $3.1 million | 0 | $0 |
| Drexel University | Philadelphia, PA | 3 | $3.1 million | 0 | $0 |
| Virtici, LLC | Seattle, WA | 1 | $3 million | 0 | $0 |
| Montana State University | Bozeman, MT | 2 | $2.9 million | 0 | $0 |
| Tulane University of Louisiana | New Orleans, LA | 3 | $2.9 million | 0 | $0 |
| Seattle Children's Hospital | Seattle, WA | 2 | $2.8 million | 0 | $0 |
| Ut Southwestern Medical Center | Dallas, TX | 3 | $2.8 million | 0 | $0 |
| University of Houston | Houston, TX | 1 | $2.8 million | 0 | $0 |
| Eydis Bio, Inc. | Durham, NC | 3 | $2.8 million | 0 | $0 |
| Weill Medical Coll of Cornell Univ | New York, NY | 3 | $2.7 million | 0 | $0 |
| University of Nebraska Medical Center | Omaha, NE | 4 | $2.6 million | 0 | $0 |
| University of Vermont & ST Agric College | Burlington, VT | 3 | $2.6 million | 0 | $0 |
| Medical College of Wisconsin | Milwaukee, WI | 3 | $2.6 million | 0 | $0 |
| Virginia Polytechnic Institute and State University | Blacksburg, VA | 4 | $2.6 million | 0 | $0 |
| Columbia University | New York, NY | 3 | $2.6 million | 0 | $0 |
| Research Inst of Fox Chase Can CTR | Philadelphia, PA | 1 | $2.5 million | 0 | $0 |
| Ohio University | Athens, OH | 3 | $2.5 million | 0 | $0 |
| Chromatan Corporation | Dedham, MA | 1 | $2.5 million | 0 | $0 |
| Spaulding Rehabilitation Hospital | Charlestown, MA | 4 | $2.5 million | 0 | $0 |
| Neuromuscular Dynamics, LLC | La Crescenta, CA | 2 | $2.5 million | 0 | $0 |
| Regenosine INC | Princeton, NJ | 2 | $2.5 million | 0 | $0 |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 506 | $273,556,682 | 0 | $0 |
| 2024 | 507 | $242,447,318 | 0 | $0 |
| 2023 | 526 | $254,555,151 | 0 | $0 |
| 2022 | 526 | $251,786,099 | 0 | $0 |
| 2021 | 520 | $241,023,272 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
Updated November 4, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-04). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.